{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 849165, "items": [{"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T13:44:26Z", "timestamp": 1574430266445}, "reference-count": 88, "publisher": "Elsevier BV", "issue": "6", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2011, 12, 1]], "date-time": "2011-12-01T00:00:00Z", "timestamp": 1322697600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Current Opinion in Virology"], "published-print": {"date-parts": [[2011, 12]]}, "DOI": "10.1016/j.coviro.2011.10.030", "type": "journal-article", "created": {"date-parts": [[2011, 12, 6]], "date-time": "2011-12-06T07:55:38Z", "timestamp": 1323158138000}, "page": "590-598", "source": "Crossref", "is-referenced-by-count": 63, "title": ["Ribavirin for the treatment of chronic hepatitis C virus infection: a review of the proposed mechanisms of action"], "prefix": "10.1016", "volume": "1", "author": [{"given": "Jan", "family": "Paeshuyse", "sequence": "first", "affiliation": []}, {"given": "Kai", "family": "Dallmeier", "sequence": "additional", "affiliation": []}, {"given": "Johan", "family": "Neyts", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Current Opinion in Virology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1879625711001647?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1879625711001647?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 20]], "date-time": "2019-06-20T10:44:14Z", "timestamp": 1561027454000}, "score": 67.99509, "issued": {"date-parts": [[2011, 12]]}, "references-count": 88, "journal-issue": {"published-print": {"date-parts": [[2011, 12]]}, "issue": "6"}, "alternative-id": ["S1879625711001647"], "URL": "http://dx.doi.org/10.1016/j.coviro.2011.10.030", "ISSN": ["1879-6257"], "issn-type": [{"value": "1879-6257", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T21:52:05Z", "timestamp": 1574113925686}, "reference-count": 20, "publisher": "Wiley", "issue": "4", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 5175, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J Viral Hepat"], "published-print": {"date-parts": [[2001, 7]]}, "DOI": "10.1046/j.1365-2893.2001.00300.x", "type": "journal-article", "created": {"date-parts": [[2003, 3, 12]], "date-time": "2003-03-12T09:19:15Z", "timestamp": 1047460755000}, "page": "287-292", "source": "Crossref", "is-referenced-by-count": 112, "title": ["Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection - a pilot study"], "prefix": "10.1111", "volume": "8", "author": [{"given": "A.", "family": "Bruchfeld", "sequence": "first", "affiliation": []}, {"given": "L.", "family": "Stahle", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Andersson", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Schvarcz", "sequence": "additional", "affiliation": []}], "member": "311", "reference": [{"key": "b1_282", "DOI": "10.1056/NEJM199506013322202", "doi-asserted-by": "publisher"}, {"key": "b2_283", "author": "Kiyosawa K", "volume": "12", "first-page": "671", "year": "1990", "journal-title": "Hepatology", "DOI": "10.1002/hep.1840120409", "doi-asserted-by": "crossref"}, {"key": "b3_284", "author": "Simon N", "volume": "46", "first-page": "504", "year": "1994", "journal-title": "Kidney Int", "DOI": "10.1038/ki.1994.301", "doi-asserted-by": "crossref"}, {"key": "b4_285", "DOI": "10.1097/00007890-199808270-00010", "doi-asserted-by": "publisher"}, {"key": "b5_286", "author": "Legendre CH", "volume": "5", "first-page": "667", "year": "1998", "journal-title": "Transplantation", "DOI": "10.1097/00007890-199803150-00011", "doi-asserted-by": "crossref"}, {"key": "b6_287", "DOI": "10.1002/hep.510290123", "doi-asserted-by": "publisher"}, {"key": "b7_288", "author": "Schvarcz R", "volume": "23", "first-page": "17", "year": "1995", "journal-title": "J Hepatol"}, {"key": "b8_289", "DOI": "10.1016/S0140-6736(98)07124-4", "doi-asserted-by": "publisher"}, {"key": "b9_290", "DOI": "10.1056/NEJM199811193392101", "doi-asserted-by": "publisher"}, {"key": "b10_291", "author": "Izopet J", "volume": "176", "first-page": "1614", "year": "1997", "journal-title": "J Infect Dis", "DOI": "10.1086/517339", "doi-asserted-by": "crossref"}, {"key": "b11_292", "author": "Huraib S", "volume": "34", "first-page": "55", "year": "1999", "journal-title": "Am J Kidney Dis", "DOI": "10.1016/S0272-6386(99)70108-3", "doi-asserted-by": "crossref"}, {"key": "b12_293", "author": "Trepo C", "volume": "11", "first-page": "62", "year": "1996", "journal-title": "Nephrol Dial Transplant", "DOI": "10.1093/ndt/11.supp4.62", "doi-asserted-by": "crossref"}, {"key": "b13_294", "author": "Kramer TH", "volume": "43", "first-page": "489", "year": "1990", "journal-title": "Antimicrob Agents Chemother", "DOI": "10.1128/AAC.34.3.489", "doi-asserted-by": "crossref"}, {"key": "b14_295", "DOI": "10.1016/S0168-8278(99)80403-6", "doi-asserted-by": "publisher"}, {"key": "b15_296", "DOI": "10.1097/00007691-200004000-00013", "doi-asserted-by": "publisher"}, {"key": "b16_297", "author": "Okamoto H", "volume": "74", "first-page": "2385", "year": "1993", "journal-title": "J Gen Virol", "DOI": "10.1099/0022-1317-74-11-2385", "doi-asserted-by": "crossref"}, {"key": "b17_298", "author": "Batts KP", "volume": "19", "first-page": "1409", "year": "1995", "journal-title": "Am J Surg Pathol", "DOI": "10.1097/00000478-199512000-00007", "doi-asserted-by": "crossref"}, {"key": "b18_299", "DOI": "10.1046/j.1365-2125.1998.00836.x", "doi-asserted-by": "publisher"}, {"key": "b19_300", "author": "Eschbach J", "volume": "35", "first-page": "135", "year": "1989", "journal-title": "Kidney Int", "DOI": "10.1038/ki.1989.18", "doi-asserted-by": "crossref"}, {"key": "b20_301", "author": "Barany P", "volume": "29", "first-page": "565", "year": "1997", "journal-title": "Am J Kidney Dis", "DOI": "10.1016/S0272-6386(97)90339-5", "doi-asserted-by": "crossref"}], "container-title": ["Journal of Viral Hepatitis"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2893.2001.00300.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 11, 10]], "date-time": "2017-11-10T06:37:39Z", "timestamp": 1510295859000}, "score": 37.470215, "issued": {"date-parts": [[2001, 7]]}, "references-count": 20, "journal-issue": {"published-print": {"date-parts": [[2001, 7]]}, "issue": "4"}, "alternative-id": ["10.1046/j.1365-2893.2001.00300.x"], "URL": "http://dx.doi.org/10.1046/j.1365-2893.2001.00300.x", "relation": {"cites": []}, "ISSN": ["1352-0504", "1365-2893"], "issn-type": [{"value": "1352-0504", "type": "print"}, {"value": "1365-2893", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T08:58:04Z", "timestamp": 1574153884805}, "reference-count": 50, "publisher": "Wiley", "issue": "5", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 4871, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Hepatology"], "published-print": {"date-parts": [[2002, 5]]}, "DOI": "10.1053/jhep.2002.32672", "type": "journal-article", "created": {"date-parts": [[2003, 2, 17]], "date-time": "2003-02-17T22:18:10Z", "timestamp": 1045520290000}, "page": "1002-1009", "source": "Crossref", "is-referenced-by-count": 217, "title": ["Mechanism of action of ribavirin in the combination treatment of chronic HCV infection"], "prefix": "10.1002", "volume": "35", "author": [{"given": "J", "family": "Lau", "sequence": "first", "affiliation": []}], "member": "311", "reference": [{"key": "10.1053/jhep.2002.32672-BIB1", "author": "Witkowski", "volume": "15", "first-page": "1150", "year": "1972", "journal-title": "J Med Chem", "DOI": "10.1021/jm00281a014", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB2", "author": "Sidwell", "volume": "177", "first-page": "705", "year": "1972", "journal-title": "Science", "DOI": "10.1126/science.177.4050.705", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB3", "author": "Choo", "volume": "244", "first-page": "359", "year": "1989", "journal-title": "Science", "DOI": "10.1126/science.2523562", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB4", "author": "Foster", "volume": "17", "first-page": "287", "year": "1997", "journal-title": "Semin Liver Dis", "DOI": "10.1055/s-2007-1007205", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB5", "author": "Lau", "volume": "275", "first-page": "g1217", "year": "1998", "journal-title": "Am J Physiol"}, {"key": "10.1053/jhep.2002.32672-BIB6", "author": "Dusheiko", "volume": "25", "first-page": "591", "year": "1996", "journal-title": "J Hepatol", "DOI": "10.1016/S0168-8278(96)80225-X", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB7", "author": "Bodenheimer", "volume": "26", "first-page": "473", "year": "1997", "journal-title": "Hepatology", "DOI": "10.1002/hep.510260231", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB8", "author": "Friebe", "volume": "75", "first-page": "12047", "year": "2001", "journal-title": "J Virol", "DOI": "10.1128/JVI.75.24.12047-12057.2001", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB9", "author": "Kolykhalov", "volume": "74", "first-page": "2046", "year": "2000", "journal-title": "J Virol", "DOI": "10.1128/JVI.74.4.2046-2051.2000", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB10", "author": "Zhong", "volume": "74", "first-page": "2017", "year": "2000", "journal-title": "J Virol", "DOI": "10.1128/JVI.74.4.2017-2022.2000", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB11", "author": "Hong", "volume": "285", "first-page": "6", "year": "2001", "journal-title": "Virology", "DOI": "10.1006/viro.2001.0948", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB12", "author": "Gilles", "volume": "16", "first-page": "655", "year": "1992", "journal-title": "Hepatology", "DOI": "10.1002/hep.1840160308", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB13", "author": "Mosmann", "volume": "17", "first-page": "138", "year": "1996", "journal-title": "Immunol Today", "DOI": "10.1016/0167-5699(96)80606-2", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB14", "author": "Tsai", "volume": "25", "first-page": "449", "year": "1997", "journal-title": "Hepatology", "DOI": "10.1002/hep.510250233", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB15", "author": "Lechmann", "volume": "31", "first-page": "971", "year": "1999", "journal-title": "J Hepatol", "DOI": "10.1016/S0168-8278(99)80307-9", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB16", "author": "Reiser", "volume": "26", "first-page": "471", "year": "1997", "journal-title": "J Hepatol", "DOI": "10.1016/S0168-8278(97)80409-6", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB17", "author": "Cacciarella", "volume": "24", "first-page": "6", "year": "1996", "journal-title": "Hepatology", "DOI": "10.1002/hep.510240102", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB18", "author": "Eckels", "volume": "60", "first-page": "187", "year": "1999", "journal-title": "J Hum Immunol", "DOI": "10.1016/S0198-8859(98)00111-6", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB19", "author": "Cramp", "volume": "44", "first-page": "424", "year": "1999", "journal-title": "Gut", "DOI": "10.1136/gut.44.3.424", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB20", "author": "Peavy", "volume": "126", "first-page": "861", "year": "1981", "journal-title": "J Immunol"}, {"key": "10.1053/jhep.2002.32672-BIB21", "author": "Edell", "volume": "25", "first-page": "154", "year": "1998", "journal-title": "Pediatric Pulmonol", "DOI": "10.1002/(SICI)1099-0496(199803)25:3<154::AID-PPUL4>3.0.CO;2-M", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB22", "author": "Tam", "volume": "30", "first-page": "376", "year": "1999", "journal-title": "J Hepatol", "DOI": "10.1016/S0168-8278(99)80093-2", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB23", "author": "Preston", "volume": "43", "first-page": "2451", "year": "1999", "journal-title": "Antimicrob Agents Chemother"}, {"key": "10.1053/jhep.2002.32672-BIB24", "author": "Tam", "volume": "44", "first-page": "1276", "year": "2000", "journal-title": "Antimicrob Agents Chemother", "DOI": "10.1128/AAC.44.5.1276-1283.2000", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB25", "author": "Fang", "volume": "33", "first-page": "791", "year": "2000", "journal-title": "J Hepatol", "DOI": "10.1016/S0168-8278(00)80312-8", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB26", "author": "Hultgren", "volume": "79", "first-page": "2381", "year": "1998", "journal-title": "J Gen Virol", "DOI": "10.1099/0022-1317-79-10-2381", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB27", "author": "Ning", "volume": "160", "first-page": "3487", "year": "1998", "journal-title": "J Immunol"}, {"key": "10.1053/jhep.2002.32672-BIB28", "author": "He", "volume": "32", "first-page": "394a", "year": "2000", "journal-title": "Hepatology", "DOI": "10.1053/jhep.2000.9143", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB29", "author": "Rigopoulou", "volume": "32", "first-page": "374a", "year": "2000", "journal-title": "Hepatology", "DOI": "10.1016/S0168-8278(00)80386-4", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB30", "author": "Martin", "volume": "10", "first-page": "635", "year": "1998", "journal-title": "Cytokine", "DOI": "10.1006/cyto.1997.0333", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB31", "author": "Rico", "volume": "33", "first-page": "295", "year": "2001", "journal-title": "Hepatology", "DOI": "10.1053/jhep.2001.21147", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB32", "author": "Cramp", "volume": "118", "first-page": "346", "year": "2000", "journal-title": "Gastroenterology", "DOI": "10.1016/S0016-5085(00)70217-4", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB33", "author": "Morishima", "volume": "32", "first-page": "367a", "year": "2000", "journal-title": "Hepatology"}, {"key": "10.1053/jhep.2002.32672-BIB34", "author": "Zitron", "volume": "30", "first-page": "374a", "year": "2000", "journal-title": "Hepatology"}, {"key": "10.1053/jhep.2002.32672-BIB35", "author": "Nelson", "volume": "28", "first-page": "225", "year": "1998", "journal-title": "Hepatology", "DOI": "10.1002/hep.510280129", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB36", "author": "Zhang", "volume": "175", "first-page": "1294", "year": "1997", "journal-title": "J Infect Dis", "DOI": "10.1086/516459", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB37", "author": "Rossi", "volume": "34", "first-page": "327a", "year": "2001", "journal-title": "Hepatology"}, {"key": "10.1053/jhep.2002.32672-BIB38", "author": "Willis", "volume": "75", "first-page": "3042", "year": "1978", "journal-title": "Proc Natl Acad Sci U S A", "DOI": "10.1073/pnas.75.7.3042", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB39", "author": "Sintchak", "volume": "47", "first-page": "163", "year": "2000", "journal-title": "Immunopharmacology", "DOI": "10.1016/S0162-3109(00)00193-4", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB40", "author": "Pankiewicz", "volume": "6", "first-page": "629", "year": "1999", "journal-title": "Curr Med Chem"}, {"key": "10.1053/jhep.2002.32672-BIB41", "author": "Markland", "volume": "44", "first-page": "859", "year": "2000", "journal-title": "Antimicrob Agents Chemother", "DOI": "10.1128/AAC.44.4.859-866.2000", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB42", "author": "Laxton", "year": "2000", "unstructured": ", , , , , , et al. Characterization of interferon-alfa-2a and pegylated interferon-alfa-2a in combination with ribavirin, mycophenolic acid or VX-497 as inhibitors of HCV replicon replication [Abstract]. 7th International Meeting on Hepatitis and Related Viruses 2000; 338."}, {"key": "10.1053/jhep.2002.32672-BIB43", "author": "Smith", "first-page": "1", "year": "1984", "unstructured": "Background and mechanisms of action of ribavirin. In: , , eds. Clinical Applications of Ribavirin. Florida: Academic Press 1984; 1-18.", "volume-title": "Clinical Applications of Ribavirin"}, {"key": "10.1053/jhep.2002.32672-BIB44", "author": "Peavy", "volume": "29", "first-page": "583", "year": "1980", "journal-title": "Infect Immunol"}, {"key": "10.1053/jhep.2002.32672-BIB45", "author": "Wright", "volume": "30", "first-page": "408a", "year": "1999", "journal-title": "Hepatology"}, {"key": "10.1053/jhep.2002.32672-BIB46", "author": "Marousis", "volume": "15", "first-page": "192", "year": "1997", "journal-title": "Dig Dis", "DOI": "10.1159/000171599", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB47", "author": "Crotty", "volume": "6", "first-page": "1375", "year": "2000", "journal-title": "Nat Med", "DOI": "10.1038/82191", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB48", "author": "Crotty", "volume": "98", "first-page": "6895", "year": "2001", "journal-title": "Proc Natl Acad Sci U S A", "DOI": "10.1073/pnas.111085598", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB49", "author": "Lanford", "volume": "75", "first-page": "8074", "year": "2001", "journal-title": "J Virol", "DOI": "10.1128/JVI.75.17.8074-8081.2001", "doi-asserted-by": "crossref"}, {"key": "10.1053/jhep.2002.32672-BIB50", "author": "Catlin", "first-page": "83", "year": "1980", "unstructured": ", . 14C-ribavirin distribution and pharmacokinetic studies in rat, baboons, and man. In: , eds. Ribavirin: A Broad Spectrum Antiviral Agent. New York: Academic Press, 1980: 83-98.", "volume-title": "Ribavirin: A Broad Spectrum Antiviral Agent"}], "container-title": ["Hepatology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1053%2Fjhep.2002.32672", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1053/jhep.2002.32672", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 2]], "date-time": "2018-08-02T04:17:11Z", "timestamp": 1533183431000}, "score": 35.065067, "issued": {"date-parts": [[2002, 5]]}, "references-count": 50, "journal-issue": {"published-print": {"date-parts": [[2002, 5]]}, "issue": "5"}, "alternative-id": ["S0270-9139(02)70301-7"], "URL": "http://dx.doi.org/10.1053/jhep.2002.32672", "relation": {"cites": []}, "ISSN": ["0270-9139"], "issn-type": [{"value": "0270-9139", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T07:54:26Z", "timestamp": 1574754866446}, "reference-count": 5, "publisher": "Wiley", "issue": "2", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2016, 2]]}, "DOI": "10.1111/ajt.13567", "type": "journal-article", "created": {"date-parts": [[2016, 1, 5]], "date-time": "2016-01-05T02:46:03Z", "timestamp": 1451961963000}, "page": "727-727", "source": "Crossref", "is-referenced-by-count": 4, "title": ["When Should Ribavirin Be Started to Treat Hepatitis E Virus Infection in Transplant Patients?"], "prefix": "10.1111", "volume": "16", "author": [{"given": "N.", "family": "Kamar", "sequence": "first", "affiliation": [{"name": "Department of Nephrology and Organ Transplantation; CHU Rangueil; Toulouse France"}, {"name": "INSERM U1043; IFR-BMT, CHU; Purpan Toulouse France"}, {"name": "Universit\u00e9 Paul Sabatier; Toulouse France"}]}, {"given": "O.", "family": "Marion", "sequence": "additional", "affiliation": [{"name": "Department of Nephrology and Organ Transplantation; CHU Rangueil; Toulouse France"}]}, {"given": "J.", "family": "Izopet", "sequence": "additional", "affiliation": [{"name": "INSERM U1043; IFR-BMT, CHU; Purpan Toulouse France"}, {"name": "Universit\u00e9 Paul Sabatier; Toulouse France"}, {"name": "Laboratory of Virology; CHU Purpan; Toulouse France"}]}], "member": "311", "published-online": {"date-parts": [[2016, 1, 4]]}, "reference": [{"key": "10.1111/ajt.13567-BIB0001|ajt13567-cit-0001", "doi-asserted-by": "crossref", "first-page": "3011", "DOI": "10.1111/ajt.13428", "article-title": "Definition of chronic hepatitis E after liver transplant conforms to convention", "volume": "15", "author": "Meisner", "year": "2015", "journal-title": "Am J Transplant"}, {"key": "10.1111/ajt.13567-BIB0002|ajt13567-cit-0002", "doi-asserted-by": "crossref", "first-page": "1935", "DOI": "10.1111/ajt.12253", "article-title": "How should hepatitis E virus infection be defined in organ-transplant recipients", "volume": "13", "author": "Kamar", "year": "2013", "journal-title": "Am J Transplant"}, {"key": "10.1111/ajt.13567-BIB0003|ajt13567-cit-0003", "doi-asserted-by": "crossref", "first-page": "353", "DOI": "10.1097/TP.0b013e3181c4096c", "article-title": "Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation", "volume": "89", "author": "Kamar", "year": "2010", "journal-title": "Transplantation"}, {"key": "10.1111/ajt.13567-BIB0004|ajt13567-cit-0004", "doi-asserted-by": "crossref", "first-page": "2477", "DOI": "10.1016/S0140-6736(11)61849-7", "article-title": "Hepatitis E", "volume": "379", "author": "Kamar", "year": "2012", "journal-title": "Lancet"}, {"key": "10.1111/ajt.13567-BIB0005|ajt13567-cit-0005", "doi-asserted-by": "crossref", "first-page": "1111", "DOI": "10.1056/NEJMoa1215246", "article-title": "Ribavirin for chronic hepatitis E virus infection in transplant recipients", "volume": "370", "author": "Kamar", "year": "2014", "journal-title": "N Engl J Med"}], "container-title": ["American Journal of Transplantation"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fajt.13567", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 24]], "date-time": "2017-06-24T03:00:37Z", "timestamp": 1498273237000}, "score": 33.52074, "subtitle": ["Chronic HEV Infection"], "issued": {"date-parts": [[2016, 1, 4]]}, "references-count": 5, "journal-issue": {"published-print": {"date-parts": [[2016, 2]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.1111/ajt.13567", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["1600-6135"], "issn-type": [{"value": "1600-6135", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T10:42:25Z", "timestamp": 1574419345617}, "publisher-location": "New York, NY", "reference-count": 41, "publisher": "Springer New York", "isbn-type": [{"value": "9781461411918", "type": "print"}, {"value": "9781461411925", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2012]]}, "DOI": "10.1007/978-1-4614-1192-5_20", "type": "book-chapter", "created": {"date-parts": [[2011, 11, 16]], "date-time": "2011-11-16T15:11:44Z", "timestamp": 1321456304000}, "page": "261-269", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Treating Chronic HCV Without Interferon and/or Ribavirin"], "prefix": "10.1007", "author": [{"given": "Edward J.", "family": "Gane", "sequence": "first", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2011, 10, 11]]}, "reference": [{"key": "20_CR1_20", "unstructured": "NCHECR Report to the Ministry of Health Advisory Committee. Hepatitis C virus projections working group: estimates and projections of the hepatitis C virus epidemic in Australia 2006. Published October 2006."}, {"key": "20_CR2_20", "unstructured": "CDC Compressed Mortality File. \n                  http://wonder.cdc.gov/controller\n                  \n                . Accessed 1 June 2008."}, {"key": "20_CR3_20", "unstructured": "National Health and Nutrition Examination Surveys 1988\u20132006. \n                  http://www.cdc.gov/nchs/about/major/nhanes\n                  \n                . Accessed 1 June 2008."}, {"key": "20_CR4_20", "doi-asserted-by": "crossref", "first-page": "705", "DOI": "10.7326/0003-4819-144-10-200605160-00004", "volume": "144", "author": "G Armstrong", "year": "2006", "unstructured": "Armstrong G, Wasley A, Simard E, et al. Prevalence of HCV infection in the United States. Ann Intern Med. 2006;144:705\u201314.", "journal-title": "Ann Intern Med"}, {"key": "20_CR5_20", "doi-asserted-by": "publisher", "first-page": "513", "DOI": "10.1053/j.gastro.2009.09.067", "volume": "138", "author": "G Davis", "year": "2010", "unstructured": "Davis G, Alter M, El-Serag H, et al. Aging of HCV infected persons in US: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology. 2010;138:513\u201321.", "journal-title": "Gastroenterology"}, {"key": "20_CR6_20", "doi-asserted-by": "publisher", "first-page": "1128", "DOI": "10.1002/hep.22165", "volume": "47", "author": "M Wise", "year": "2008", "unstructured": "Wise M, Bialek S, Bell B, et al. Changing trends in HCV-related mortality in USA. Hepatology. 2008;47:1128\u201335.", "journal-title": "Hepatology"}, {"key": "20_CR7_20", "doi-asserted-by": "publisher", "first-page": "1372", "DOI": "10.1053/j.gastro.2004.07.020", "volume": "127", "author": "J Davila", "year": "2004", "unstructured": "Davila J, Morgan R, Shaib Y, et al. HCV and increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology. 2004;127:1372\u201380.", "journal-title": "Gastroenterology"}, {"key": "20_CR8_20", "doi-asserted-by": "publisher", "first-page": "331", "DOI": "10.1053/jlts.2003.50073", "volume": "9", "author": "G Davis", "year": "2003", "unstructured": "Davis G, Albright J, Cook S. Projecting future complications of chronic hepatitis C in United States. Liver Transpl. 2003;9:331\u20138.", "journal-title": "Liver Transpl"}, {"key": "20_CR9_20", "doi-asserted-by": "publisher", "first-page": "958", "DOI": "10.1016/S0140-6736(01)06102-5", "volume": "358", "author": "MP Manns", "year": "2001", "unstructured": "Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon a-2b plus ribavirin compared with interferon a-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet. 2001;358:958\u201365.", "journal-title": "Lancet"}, {"key": "20_CR10_20", "first-page": "428A", "volume": "52", "author": "L Backus", "year": "2010", "unstructured": "Backus L, Boothroyd D, Philips B, et al. Impact of SVR to PegIFN/Ribavirib on all cause mortality by HCV genotype in a large real world cohort. Hepatology. 2010;52:428A.", "journal-title": "Hepatology"}, {"key": "20_CR11_20", "doi-asserted-by": "publisher", "first-page": "399", "DOI": "10.1038/nature08309", "volume": "461", "author": "D Ge", "year": "2009", "unstructured": "Ge D, Fellay J, Thompson A, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature. 2009;461:399\u2013401.", "journal-title": "Nature"}, {"key": "20_CR12_20", "doi-asserted-by": "publisher", "first-page": "1100", "DOI": "10.1038/ng.447", "volume": "41", "author": "V Suppiah", "year": "2009", "unstructured": "Suppiah V, Moldovan M, Ahlenstiel G, et al. IL28B is associated with response to chronic hepatitis C interferonalpha and ribavirin therapy. Nat Genet. 2009;41:1100\u20134.", "journal-title": "Nat Genet"}, {"key": "20_CR13_20", "doi-asserted-by": "publisher", "first-page": "1105", "DOI": "10.1038/ng.449", "volume": "41", "author": "Y Tanaka", "year": "2009", "unstructured": "Tanaka Y, Nishida N, Sugiyama M, et al. Genome-wide association of IL28B with response to pegylated interferonalpha and ribavirin therapy for chronic hepatitis C. Nat Genet. 2009;41:1105\u20139.", "journal-title": "Nat Genet"}, {"issue": "3", "key": "20_CR14_20", "doi-asserted-by": "publisher", "first-page": "452", "DOI": "10.1016/j.jhep.2009.11.016", "volume": "52", "author": "T Asselah", "year": "2010", "unstructured": "Asselah T. Genetic polymorphism and response to treatment in chronic hepatitis C: the future of personalized medicine. J Hepatol. 2010;52(3):452\u20134.", "journal-title": "J Hepatol"}, {"key": "20_CR15_20", "doi-asserted-by": "publisher", "first-page": "997", "DOI": "10.1053/he.2000.5789", "volume": "31", "author": "L Franceschi De", "year": "2000", "unstructured": "De Franceschi L, Fattovich G, Turrini F, et al. Haemolytic anaemia induced by ribavirin therapy in patients with chronic HCV infection: role of membrane oxidative damage. Hepatology. 2000;31:997\u20131004.", "journal-title": "Hepatology"}, {"key": "20_CR16_20", "doi-asserted-by": "publisher", "first-page": "1485", "DOI": "10.1056/NEJM199811193392101", "volume": "339", "author": "J McHutchinson", "year": "1998", "unstructured": "McHutchinson J, Gordon S, Schiff E, et al. Interferon 2b alone or in combination with ribavirin as initial treatment of chronic hepatitis C. N Engl J Med. 1998;339:1485\u201392.", "journal-title": "N Engl J Med"}, {"key": "20_CR17_20", "doi-asserted-by": "publisher", "first-page": "371", "DOI": "10.1002/hep.21712", "volume": "46", "author": "M Shiffman", "year": "2007", "unstructured": "Shiffman M, Salvatore J, Hubbard S, et al. Treatment of chronic hepatitis C genotype 1 with peginterferon, ribavirin and epoetin alpha. Hepatology. 2007;46:371\u20139.", "journal-title": "Hepatology"}, {"key": "20_CR18_20", "doi-asserted-by": "publisher", "first-page": "768", "DOI": "10.1016/j.jhep.2006.12.016", "volume": "46", "author": "M Rendina", "year": "2007", "unstructured": "Rendina M, Schena A, Castellaneta N, et al. The treatment of chronic hepatitis C with peginterferon alfa-2a (40 kDa) plus ribavirin in haemodialysed patients awaiting renal transplant. J Hepatol. 2007;46:768\u201374.", "journal-title": "J Hepatol"}, {"key": "20_CR19_20", "doi-asserted-by": "publisher", "first-page": "405", "DOI": "10.1038/nature08825", "volume": "464", "author": "J Fellay", "year": "2010", "unstructured": "Fellay J, Thompson AJ, Ge D, Gumbs CE, et al. ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C. Nature. 2010;464:405\u20138.", "journal-title": "Nature"}, {"key": "20_CR20_20", "first-page": "427A", "volume": "52", "author": "I Jacobson", "year": "2010", "unstructured": "Jacobson I, McHutchison J, Dusheiko G, et al. Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection. N Engl J Med 2011;364: 2405\u201316.", "journal-title": "Hepatology"}, {"key": "20_CR21_20", "doi-asserted-by": "publisher", "first-page": "402A", "DOI": "10.1002/hep.23827", "volume": "52", "author": "F Poordad", "year": "2010", "unstructured": "Poordad F, McCone J, Bacon B, et al. Boceprevir for Untreated Chronic HCV Genotype 1 Infection. N Engl J Med 2011;364: 1195\u2013206.", "journal-title": "Hepatology"}, {"key": "20_CR22_20", "doi-asserted-by": "publisher", "first-page": "1292", "DOI": "10.1056/NEJMoa0908014", "volume": "362", "author": "JG McHutchison", "year": "2010", "unstructured": "Zeuzem S, Pol S, Lawitz E, et al. Telaprevir for retreatment of HCV infection N Engl J Med. 2011; 364:2417\u201328.", "journal-title": "N Engl J Med"}, {"key": "20_CR23_20", "doi-asserted-by": "publisher", "first-page": "S2", "DOI": "10.1016/S0168-8278(10)60006-2", "volume": "52", "author": "T Berg", "year": "2010", "unstructured": "Berg T, McHutchison N. Adda, et al. SVr with telaprevir, peginterferon alfa-2a and ribavirin in HCV patients with well-characterized prior null response, partial response, viral breakthrough or relapse after PR: rollover study. J Hepatol. 2010;52:S2.", "journal-title": "J Hepatol"}, {"key": "20_CR24_20", "first-page": "430A", "volume": "52", "author": "R Bruce", "year": "2010", "unstructured": "Bacon B, Gordon S, Lawitz S, et al. Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection. N Engl J Med 2011;364:1207\u201317.", "journal-title": "Hepatology"}, {"issue": "Suppl 1", "key": "20_CR25_20", "doi-asserted-by": "publisher", "first-page": "57", "DOI": "10.1111/j.1478-3231.2008.01928.x", "volume": "29", "author": "T Asselah", "year": "2009", "unstructured": "Asselah T, Benhamou Y, Marcellin P. Protease and polymerase inhibitors for the treatment of hepatitis C. Liver Int. 2009;29 Suppl 1:57\u201367.", "journal-title": "Liver Int"}, {"key": "20_CR26_20", "doi-asserted-by": "publisher", "first-page": "S27", "DOI": "10.1016/S0168-8278(10)60059-1", "volume": "52", "author": "G Foster", "year": "2010", "unstructured": "Foster G, H\u00e9zode C, Bronowicki JP, et al. Activity of telaprevir alone or in combination with peginterferon alfa-2a and ribavirin in treatment-na\u00efve, genotype 2 and 3, hepatitis C patients: final results of study C209. J Hepatol. 2010;52:S27.", "journal-title": "J Hepatol"}, {"key": "20_CR27_20", "doi-asserted-by": "publisher", "first-page": "1153A", "DOI": "10.1002/hep.22509", "volume": "48", "author": "H Tan", "year": "2008", "unstructured": "Tan H, Rajyaguru S, Wu T, et al. Combination of NS3/4a protease inhibitor ITMN-191 (R7227) with the active moiety of the NS5b inhibitors R1626 or R7128 enhances viral clearance and reduces emergence of drug-resistant variants. Hepatology. 2008;48:1153A.", "journal-title": "Hepatology"}, {"key": "20_CR28_20", "doi-asserted-by": "publisher", "first-page": "A1867", "DOI": "10.1002/hep.23824", "volume": "52", "author": "H Mo", "year": "2010", "unstructured": "Mo H, Yang H, Robinson M, et al. Enhanced in vitro activity ad suppression of resistance by combining GS-9256 with GS-9190. Hepatology. 2010;52:A1867.", "journal-title": "Hepatology"}, {"key": "20_CR29_20", "first-page": "A1853", "volume": "52", "author": "M Gao", "year": "2010", "unstructured": "Gao M, Wang C, Sun J, et al. Genotypic and phenotypic analysis of HCV NS5A inhibitor resistance variants. Hepatology. 2010;52:A1853.", "journal-title": "Hepatology"}, {"key": "20_CR30_20", "doi-asserted-by": "publisher", "first-page": "78", "DOI": "10.1016/j.antiviral.2006.07.009", "volume": "73", "author": "G Koev", "year": "2007", "unstructured": "Koev G, Dekhtyar T, Han L, et al. Antiviral interactions of an HCV polymerase inhibitor with an HCV protease inhibitor or interferon in vitro. Antiviral Res. 2007;73:78\u201383.", "journal-title": "Antiviral Res"}, {"key": "20_CR31_20", "doi-asserted-by": "publisher", "first-page": "S400", "DOI": "10.1016/S0168-8278(10)61035-5", "volume": "52", "author": "V Zennou", "year": "2010", "unstructured": "Zennou V, Lam A, Keilman M, et al. Combination of two complementary mucleotide analogues PSI7977 and PSI938 effectively clears wild type and NS5b-S282T HCV replicons. J Hepatol. 2010;52:S400.", "journal-title": "J Hepatol"}, {"key": "20_CR32_20", "doi-asserted-by": "publisher", "first-page": "S298", "DOI": "10.1016/S0168-8278(07)62389-7", "volume": "46", "author": "DB Olsen", "year": "2007", "unstructured": "Olsen DB, Carroll SS, Handt L, et al. HCV antiviral activity andresistance analysis in chronically infected chimpanzees treated with NS3/4A protease and NS513 polymerase inhibitors. J Hepatol. 2007;46:S298.", "journal-title": "J Hepatol"}, {"key": "20_CR33_20", "doi-asserted-by": "publisher", "first-page": "1467", "DOI": "10.1016/S0140-6736(10)61384-0", "volume": "376", "author": "E Gane", "year": "2010", "unstructured": "Gane E, Roberts S, Stedman C, et al. Interferon-free oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and protease inhibitor (danoprevir/RG7227) for the treatment of chronic hepatitis C genotype 1 infection: results of the INFORM-1 trial. Lancet. 2010;376:1467\u201375.", "journal-title": "Lancet"}, {"key": "20_CR34_20", "doi-asserted-by": "publisher", "first-page": "1145", "DOI": "10.1126/science.1082604", "volume": "300", "author": "E Foy", "year": "2003", "unstructured": "Foy E, Li K, Wang C, Sumpter Jr R, Ikeda M, Lemon SM, et al. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science. 2003;300:1145\u20138.", "journal-title": "Science"}, {"key": "20_CR35_20", "doi-asserted-by": "publisher", "first-page": "516", "DOI": "10.1136/gut.2007.128611", "volume": "57", "author": "T Asselah", "year": "2008", "unstructured": "Asselah T, Bieche I, Narguet S, et al. Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C. Gut. 2008;57:516\u201324.", "journal-title": "Gut"}, {"key": "20_CR36_20", "doi-asserted-by": "publisher", "first-page": "1617", "DOI": "10.1002/hep.21407", "volume": "44", "author": "M Lagging", "year": "2006", "unstructured": "Lagging M, Romero AI, Westin J, et al. IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection. Hepatology. 2006;44:1617\u201325.", "journal-title": "Hepatology"}, {"key": "20_CR37_20", "unstructured": "Shulman N, Smith P, Ipe D, et al. Reduction of IP10, a biomarker of endogenous IFN, during therapy with two direct-acting antiviral agents (DAA-combo) in INFORM-1 suggests that reducing HCV RNA with IFN-free therapy may enhance response to interferons. In: 16th international symposium on HCV and related viruses, Nice, France, 3\u20137 Oct 2009."}, {"key": "20_CR38_20", "doi-asserted-by": "publisher", "first-page": "1839", "DOI": "10.1056/NEJMoa0807650", "volume": "360", "author": "C H\u00e9zode", "year": "2009", "unstructured": "H\u00e9zode C, Forestier N, Dusheiko G, et al. Telaprevir and peginterferon with or without ribavirin for chronic HCV infection. N Engl J Med. 2009;360:1839\u201350.", "journal-title": "N Engl J Med"}, {"key": "20_CR39_20", "doi-asserted-by": "crossref", "first-page": "25", "DOI": "10.1177/095632020801900104", "volume": "19", "author": "L Bassit", "year": "2008", "unstructured": "Bassit L, Grier J, Bennett M, et al. Combinations of 2\u2032-C-methylcytidine analogues with interferon-alpha2b and triple combination with ribavirin in the hepatitis C virus replicon system. Antivir Chem Chemother. 2008;19:25\u201331.", "journal-title": "Antivir Chem Chemother"}, {"key": "20_CR40_20", "unstructured": "Lok A, Gardiner D, Lawitz J, et al. Combination Therapy With BMS-790052 and BMS-650032 Alone or With Pegylated Interferon and Ribavirin (pegIFN/RBV) Results in Undetectable HCV RNA Through 12 Weeks of Therapy in HCV Genotype 1 Null Responders. Hepatology 2010;52:877A. Abstract LB-8"}, {"key": "20_CR41_20", "doi-asserted-by": "publisher", "first-page": "1769", "DOI": "10.1002/hep.22549", "volume": "48", "author": "T Kuntzen", "year": "2008", "unstructured": "Kuntzen T, Timm J, Berical A, et al. Naturally occurring dominant resistant mutations to HCV protease and polymerase inhibitors in treatment-naive patients. Hepatology. 2008;48:1769\u201378.", "journal-title": "Hepatology"}], "container-title": ["Chronic Hepatitis C Virus"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-1-4614-1192-5_20", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 18]], "date-time": "2019-04-18T07:30:52Z", "timestamp": 1555572652000}, "score": 33.09802, "issued": {"date-parts": [[2011, 10, 11]]}, "ISBN": ["9781461411918", "9781461411925"], "references-count": 41, "URL": "http://dx.doi.org/10.1007/978-1-4614-1192-5_20", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 29]], "date-time": "2019-11-29T22:44:45Z", "timestamp": 1575067485499}, "reference-count": 10, "publisher": "Wiley", "issue": "2", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 3836, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J Viral Hepat"], "published-print": {"date-parts": [[2005, 3]]}, "DOI": "10.1111/j.1365-2893.2005.00565.x", "type": "journal-article", "created": {"date-parts": [[2005, 2, 17]], "date-time": "2005-02-17T20:53:59Z", "timestamp": 1108673639000}, "page": "125-129", "source": "Crossref", "is-referenced-by-count": 11, "title": ["Intrahepatic and peripheral blood virus-specific cytotoxic T lymphocyte activity is associated with a response to combination IFN-alpha and ribavirin treatment among patients with chronic hepatitis C virus infection*"], "prefix": "10.1111", "volume": "12", "author": [{"given": "A. J.", "family": "Freeman", "sequence": "first", "affiliation": []}, {"given": "G.", "family": "Marinos", "sequence": "additional", "affiliation": []}, {"given": "R. A.", "family": "Ffrench", "sequence": "additional", "affiliation": []}, {"given": "A. R.", "family": "Lloyd", "sequence": "additional", "affiliation": []}], "member": "311", "reference": [{"key": "b1_78", "DOI": "10.1056/NEJM200107053450107", "doi-asserted-by": "publisher"}, {"issue": "10", "key": "b2_79", "first-page": "7092", "volume": "70", "author": "Rehermann B", "year": "1996", "journal-title": "J Virol"}, {"issue": "3", "key": "b3_80", "first-page": "1473", "volume": "158", "author": "Nelson DR", "year": "1997", "journal-title": "J Immunol"}, {"key": "b4_81", "DOI": "10.1016/S0168-8278(02)00424-5", "doi-asserted-by": "publisher"}, {"key": "b5_82", "DOI": "10.1002/hep.510280129", "doi-asserted-by": "publisher"}, {"key": "b6_83", "DOI": "10.1016/S0168-8278(99)80030-0", "doi-asserted-by": "publisher"}, {"issue": "6", "key": "b7_84", "doi-asserted-by": "crossref", "first-page": "1432", "DOI": "10.1172/JCI118931", "volume": "98", "author": "Rehermann B", "year": "1996", "journal-title": "J Clin Invest"}, {"issue": "1", "key": "b8_85", "first-page": "57", "volume": "19", "author": "McHutchison JG", "year": "1999", "journal-title": "Semin Liver Dis"}, {"issue": "3", "key": "b9_86", "first-page": "1385", "volume": "67", "author": "Grakoui A", "year": "1993", "journal-title": "J Virol"}, {"key": "b10_87", "DOI": "10.1016/0270-9139(95)90608-8", "doi-asserted-by": "publisher"}], "container-title": ["Journal of Viral Hepatitis"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2893.2005.00565.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 27]], "date-time": "2019-01-27T20:20:06Z", "timestamp": 1548620406000}, "score": 32.11368, "issued": {"date-parts": [[2005, 3]]}, "references-count": 10, "journal-issue": {"published-print": {"date-parts": [[2005, 3]]}, "issue": "2"}, "alternative-id": ["10.1111/j.1365-2893.2005.00565.x"], "URL": "http://dx.doi.org/10.1111/j.1365-2893.2005.00565.x", "relation": {"cites": []}, "ISSN": ["1352-0504", "1365-2893"], "issn-type": [{"value": "1352-0504", "type": "print"}, {"value": "1365-2893", "type": "electronic"}], "subject": ["Hepatology", "Virology", "Infectious Diseases"]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T13:32:49Z", "timestamp": 1575293569420}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2008, 4, 1]], "date-time": "2008-04-01T00:00:00Z", "timestamp": 1207008000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Gastroenterology"], "published-print": {"date-parts": [[2008, 4]]}, "DOI": "10.1016/s0016-5085(08)63803-2", "type": "journal-article", "created": {"date-parts": [[2008, 8, 1]], "date-time": "2008-08-01T09:04:43Z", "timestamp": 1217581483000}, "page": "A-814", "source": "Crossref", "is-referenced-by-count": 0, "title": ["T1010 Racial/Ethnic Minorities with Chronic Hepatitis C Virus Infection Have More Severe Fatigue Than White Patients with Chronic Hepatitis C Virus Infection"], "prefix": "10.1016", "volume": "134", "author": [{"given": "Sabina", "family": "Berezovskaya", "sequence": "first", "affiliation": []}, {"given": "Edmund J.", "family": "Bini", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Gastroenterology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0016508508638032?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0016508508638032?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 26]], "date-time": "2018-12-26T20:51:28Z", "timestamp": 1545857488000}, "score": 32.012222, "issued": {"date-parts": [[2008, 4]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2008, 4]]}, "issue": "4"}, "alternative-id": ["S0016508508638032"], "URL": "http://dx.doi.org/10.1016/s0016-5085(08)63803-2", "ISSN": ["0016-5085"], "issn-type": [{"value": "0016-5085", "type": "print"}], "subject": ["Gastroenterology"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T12:02:53Z", "timestamp": 1574164973919}, "reference-count": 63, "publisher": "Informa UK Limited", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Expert Review of Anti-infective Therapy"], "published-print": {"date-parts": [[2004, 8]]}, "DOI": "10.1586/14787210.2.4.475", "type": "journal-article", "created": {"date-parts": [[2005, 1, 13]], "date-time": "2005-01-13T13:49:19Z", "timestamp": 1105624159000}, "page": "475-483", "source": "Crossref", "is-referenced-by-count": 15, "title": ["Adefovir dipivoxil in the treatment of chronic hepatitis B virus infection"], "prefix": "10.1586", "volume": "2", "author": [{"given": "Stephanos J", "family": "Hadziyannis", "sequence": "first", "affiliation": []}, {"given": "George V", "family": "Papatheodoridis", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2014, 1, 10]]}, "reference": [{"key": "CIT0001", "DOI": "10.1053/gast.2001.24839", "doi-asserted-by": "publisher"}, {"key": "CIT0003", "author": "EASL International consensus conference on hepatitis B", "volume": "39", "issue": "1", "year": "2003", "journal-title": "J. Hepatol"}, {"key": "CIT0005", "author": "Papatheodoridis GV", "volume": "19", "first-page": "25", "year": "2004", "journal-title": "Aliment. Pharmacol Ther", "DOI": "10.1046/j.1365-2036.2003.01810.x", "doi-asserted-by": "crossref"}, {"key": "CIT0007", "author": "Karayiannis P", "volume": "51", "first-page": "761", "year": "2003", "journal-title": "J. Antimicrob. Chemother", "DOI": "10.1093/jac/dkg163", "doi-asserted-by": "crossref"}, {"key": "CIT0008", "DOI": "10.1111/j.1572-0241.2002.05819.x", "doi-asserted-by": "publisher"}, {"key": "CIT0009", "author": "Dando T", "volume": "63", "first-page": "2215", "year": "2003", "journal-title": "Drugs", "DOI": "10.2165/00003495-200363200-00007", "doi-asserted-by": "crossref"}, {"key": "CIT0010", "author": "Cundy KC", "volume": "36", "first-page": "127", "year": "1999", "journal-title": "Clin. Pharmacokinet", "DOI": "10.2165/00003088-199936020-00004", "doi-asserted-by": "crossref"}, {"key": "CIT0011", "author": "Torresi J", "volume": "118", "year": "2000", "journal-title": "Gastroenterology", "DOI": "10.1016/S0016-5085(00)70008-4", "doi-asserted-by": "crossref"}, {"key": "CIT0012", "author": "Yokota T", "volume": "5", "first-page": "57", "year": "1994", "journal-title": "Antivir Chem. Chemother", "DOI": "10.1177/095632029400500201", "doi-asserted-by": "crossref"}, {"key": "CIT0013", "author": "Naesens L", "volume": "8", "first-page": "1", "year": "1997", "journal-title": "Antivir. Chem. Chemother", "DOI": "10.1177/095632029700800101", "doi-asserted-by": "crossref"}, {"key": "CIT0014", "author": "Birkus G", "volume": "10", "first-page": "10", "year": "2003", "journal-title": "J. Viral Hepat", "DOI": "10.1046/j.1365-2893.2003.00399.x", "doi-asserted-by": "crossref"}, {"key": "CIT0015", "author": "Heijtink RA", "volume": "38", "first-page": "2180", "year": "1994", "journal-title": "Antimicrob. Agents Chemother", "DOI": "10.1128/AAC.38.9.2180", "doi-asserted-by": "crossref"}, {"key": "CIT0016", "author": "Heijtink RA", "volume": "21", "first-page": "141", "year": "1993", "journal-title": "Antiviral Res", "DOI": "10.1016/0166-3542(93)90050-S", "doi-asserted-by": "crossref"}, {"key": "CIT0017", "DOI": "10.1016/0168-8278(95)80277-0", "doi-asserted-by": "publisher"}, {"key": "CIT0018", "author": "Yokota T", "volume": "35", "first-page": "394", "year": "1991", "journal-title": "Antimicrob. Agents Chemother", "DOI": "10.1128/AAC.35.2.394", "doi-asserted-by": "crossref"}, {"key": "CIT0019", "author": "Yang H", "volume": "38", "issue": "1", "year": "2003", "journal-title": "Hepatology"}, {"issue": "1", "key": "CIT0020", "doi-asserted-by": "crossref", "first-page": "20", "DOI": "10.1016/S0168-8278(04)90057-8", "volume": "40", "author": "Qi X", "year": "2004", "journal-title": "J. Hepatol"}, {"key": "CIT0021", "author": "Xiong S", "volume": "38", "issue": "2", "year": "2003", "journal-title": "J. Hepatol"}, {"key": "CIT0022", "DOI": "10.1016/S0016-5085(03)00939-9", "doi-asserted-by": "publisher"}, {"key": "CIT0023", "author": "Westland CE", "volume": "38", "first-page": "96", "year": "2003", "journal-title": "Hepatology", "DOI": "10.1053/jhep.2003.50288", "doi-asserted-by": "crossref"}, {"key": "CIT0024", "author": "Hadziyannis SJ", "volume": "38", "issue": "2", "year": "2003", "journal-title": "J. Hepatol"}, {"key": "CIT0025", "author": "Hadziyannis SJ", "volume": "40", "issue": "1", "year": "2004", "journal-title": "J. Hepatol", "DOI": "10.1016/j.jhep.2010.12.030", "doi-asserted-by": "crossref"}, {"key": "CIT0027", "author": "Yang H", "volume": "40", "issue": "1", "year": "2004", "journal-title": "In vitro", "DOI": "10.1007/BF02618202", "doi-asserted-by": "crossref"}, {"key": "CIT0028", "author": "Aloman C", "volume": "38", "first-page": "1584", "year": "2003", "journal-title": "Hepatology", "DOI": "10.1002/hep.510380633", "doi-asserted-by": "crossref"}, {"key": "CIT0029", "author": "Kearney B", "volume": "36", "issue": "1", "year": "2002", "journal-title": "J. Hepatol"}, {"key": "CIT0030", "author": "Knight W", "volume": "36", "issue": "1", "year": "2002", "journal-title": "J. HepatoL", "DOI": "10.1016/j.jhep.2006.08.015", "doi-asserted-by": "crossref"}, {"key": "CIT0031", "author": "Hannon H", "volume": "19", "first-page": "386", "year": "2004", "journal-title": "NephroL Dial. Transplant", "DOI": "10.1093/ndt/gfg505", "doi-asserted-by": "crossref"}, {"key": "CIT0032", "author": "Kearney B", "volume": "36", "issue": "1", "year": "2002", "journal-title": "J. HepatoL"}, {"key": "CIT0033", "DOI": "10.1056/NEJMoa020681", "doi-asserted-by": "publisher"}, {"issue": "1", "key": "CIT0035", "doi-asserted-by": "crossref", "first-page": "122", "DOI": "10.1016/S0168-8278(02)80436-6", "volume": "36", "author": "Marcellin P", "year": "2002", "journal-title": "J. HepatoL"}, {"issue": "1", "key": "CIT0036", "doi-asserted-by": "crossref", "first-page": "110", "DOI": "10.1016/S0168-8278(02)80391-9", "volume": "36", "author": "Heathcote E", "year": "2002", "journal-title": "J. HepatoL"}, {"key": "CIT0037", "DOI": "10.1056/NEJMoa021812", "doi-asserted-by": "publisher"}, {"key": "CIT0039", "author": "Hadziyannis SJ", "volume": "23", "first-page": "81", "year": "2003", "journal-title": "Semin. Liver Dis", "DOI": "10.1055/s-2003-37584", "doi-asserted-by": "crossref"}, {"key": "CIT0041", "author": "Hadziyannis SJ", "volume": "39", "issue": "1", "year": "2003", "journal-title": "J. HepatoL", "DOI": "10.1016/j.jhep.2010.12.030", "doi-asserted-by": "crossref"}, {"key": "CIT0042", "author": "Zoulim F", "volume": "38", "issue": "2", "year": "2003", "journal-title": "J. HepatoL"}, {"key": "CIT0043", "author": "Westland CE", "volume": "34", "first-page": "446A", "year": "2001", "journal-title": "Hepatology"}, {"key": "CIT0044", "DOI": "10.1053/jhep.2000.8626", "doi-asserted-by": "publisher"}, {"key": "CIT0045", "author": "Ahmad J", "volume": "32", "year": "2000", "journal-title": "Hepatology"}, {"key": "CIT0046", "author": "Schiff ER", "volume": "38", "first-page": "1419", "year": "2003", "journal-title": "Hepatology"}, {"key": "CIT0048", "DOI": "10.1053/j.gastro.2003.10.050", "doi-asserted-by": "publisher"}, {"key": "CIT0050", "author": "Kuwahara R", "volume": "49", "first-page": "300", "year": "2004", "journal-title": "Dig. Dis. Sci", "DOI": "10.1023/B:DDAS.0000017455.39171.56", "doi-asserted-by": "crossref"}, {"key": "CIT0051", "author": "Willems B", "volume": "7", "first-page": "L111\u2014L112", "year": "2002", "journal-title": "Antiviral Ther"}, {"key": "CIT0052", "DOI": "10.1053/j.gastro.2003.10.051", "doi-asserted-by": "publisher"}, {"key": "CIT0054", "author": "Benhamou Y", "volume": "358", "first-page": "718", "year": "2001", "journal-title": "Lancet", "DOI": "10.1016/S0140-6736(01)05840-8", "doi-asserted-by": "crossref"}, {"key": "CIT0055", "author": "Dore GJ", "volume": "189", "first-page": "1185", "year": "2004", "journal-title": "J. Infect. Dis", "DOI": "10.1086/380398", "doi-asserted-by": "crossref"}, {"key": "CIT0056", "author": "Lerbaek A", "volume": "36", "first-page": "280", "year": "2004", "journal-title": "Scand. J. Infect. Dis", "DOI": "10.1080/00365540410019633", "doi-asserted-by": "crossref"}, {"key": "CIT0057", "author": "Lessells R", "volume": "23", "first-page": "366", "year": "2004", "journal-title": "Eur. J. Clin. MicrobioL Infect. Dis", "DOI": "10.1007/s10096-004-1127-3", "doi-asserted-by": "crossref"}, {"key": "CIT0058", "author": "Benhamou Y", "volume": "38", "issue": "2", "year": "2004", "journal-title": "Clin. Infect. Dis"}, {"key": "CIT0059", "author": "Benhamou Y", "volume": "39", "issue": "1", "year": "2003", "journal-title": "J. HepatoL"}, {"key": "CIT0060", "author": "Deeks SG", "volume": "176", "first-page": "1517", "year": "1997", "journal-title": "J. Infect. Dis", "DOI": "10.1086/514150", "doi-asserted-by": "crossref"}, {"key": "CIT0061", "author": "Dusheiko G", "volume": "39", "issue": "1", "year": "2003", "journal-title": "J. HepatoL"}, {"key": "CIT0062", "author": "Westland C", "volume": "125", "first-page": "107", "year": "2003", "journal-title": "Gastroenterology", "DOI": "10.1016/S0016-5085(03)00700-5", "doi-asserted-by": "crossref"}, {"key": "CIT0064", "DOI": "10.1053/jhep.2001.29401", "doi-asserted-by": "publisher"}, {"key": "CIT0065", "author": "Papatheodoridis GV", "volume": "36", "first-page": "219", "year": "2002", "journal-title": "Hepatology", "DOI": "10.1053/jhep.2002.33894", "doi-asserted-by": "crossref"}, {"key": "CIT0066", "author": "Dienstag JL", "volume": "124", "first-page": "105", "year": "2003", "journal-title": "Gastroenterology", "DOI": "10.1053/gast.2003.50013", "doi-asserted-by": "crossref"}, {"key": "CIT0067", "author": "Keeffe EB", "volume": "2", "first-page": "87", "year": "2004", "journal-title": "Clin. Gastroenterol. Hepatol", "DOI": "10.1016/S1542-3565(03)00312-4", "doi-asserted-by": "crossref"}, {"key": "CIT0069", "author": "Mailliard ME", "volume": "348", "first-page": "848", "year": "2003", "journal-title": "N EngL J. Med", "DOI": "10.1056/NEJMe020185", "doi-asserted-by": "crossref"}, {"key": "CIT0071", "author": "Sung JJY", "volume": "38", "issue": "2", "year": "2003", "journal-title": "J. HepatoL"}, {"key": "CIT0072", "author": "Marcellin P", "volume": "40", "issue": "1", "year": "2004", "journal-title": "J. HepatoL"}, {"key": "CIT0074", "author": "Santantonio T", "volume": "36", "first-page": "799", "year": "2002", "journal-title": "J. HepatoL", "DOI": "10.1016/S0168-8278(02)00056-9", "doi-asserted-by": "crossref"}, {"key": "CIT0075", "author": "Schiff ER", "volume": "38", "first-page": "818", "year": "2003", "journal-title": "J. HepatoL", "DOI": "10.1016/S0168-8278(03)00076-X", "doi-asserted-by": "crossref"}, {"key": "CIT0076", "author": "Barbaro G", "volume": "35", "first-page": "406", "year": "2001", "journal-title": "J. Hepatol", "DOI": "10.1016/S0168-8278(01)00145-3", "doi-asserted-by": "crossref"}, {"key": "CIT0078", "author": "Shaw T", "volume": "126", "first-page": "343", "year": "2004", "journal-title": "Gastroenterology", "DOI": "10.1053/j.gastro.2003.11.022", "doi-asserted-by": "crossref"}], "container-title": ["Expert Review of Anti-infective Therapy"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1586/14787210.2.4.475", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 1, 14]], "date-time": "2019-01-14T02:01:30Z", "timestamp": 1547431290000}, "score": 31.101433, "issued": {"date-parts": [[2004, 8]]}, "references-count": 63, "journal-issue": {"published-online": {"date-parts": [[2014, 1, 10]]}, "published-print": {"date-parts": [[2004, 8]]}, "issue": "4"}, "alternative-id": ["10.1586/14787210.2.4.475"], "URL": "http://dx.doi.org/10.1586/14787210.2.4.475", "relation": {"cites": []}, "ISSN": ["1478-7210", "1744-8336"], "issn-type": [{"value": "1478-7210", "type": "print"}, {"value": "1744-8336", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T19:58:40Z", "timestamp": 1574107120374}, "reference-count": 1, "publisher": "Elsevier BV", "issue": "1-2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1997, 2, 1]], "date-time": "1997-02-01T00:00:00Z", "timestamp": 854755200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Transplantation Proceedings"], "published-print": {"date-parts": [[1997, 2]]}, "DOI": "10.1016/s0041-1345(96)00100-5", "type": "journal-article", "created": {"date-parts": [[2002, 7, 26]], "date-time": "2002-07-26T01:10:51Z", "timestamp": 1027645851000}, "page": "783", "source": "Crossref", "is-referenced-by-count": 47, "title": ["Treatment of hepatitis C virus infection with ribavirin in kidney transplant patients"], "prefix": "10.1016", "volume": "29", "author": [{"given": "J.-L.", "family": "Garnier", "sequence": "first", "affiliation": []}, {"given": "P.", "family": "Chevallier", "sequence": "additional", "affiliation": []}, {"given": "J.-M.", "family": "Dubernard", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Trepo", "sequence": "additional", "affiliation": []}, {"given": "J.-L.", "family": "Touraine", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "Chossegros", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Transplantation Proceedings"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0041134596001005?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0041134596001005?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 16]], "date-time": "2019-04-16T02:26:34Z", "timestamp": 1555381594000}, "score": 31.001472, "issued": {"date-parts": [[1997, 2]]}, "references-count": 1, "journal-issue": {"published-print": {"date-parts": [[1997, 2]]}, "issue": "1-2"}, "alternative-id": ["S0041134596001005"], "URL": "http://dx.doi.org/10.1016/s0041-1345(96)00100-5", "ISSN": ["0041-1345"], "issn-type": [{"value": "0041-1345", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T07:53:18Z", "timestamp": 1575445998662}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "5", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1978, 5, 1]], "date-time": "1978-05-01T00:00:00Z", "timestamp": 262828800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Gastroenterology"], "published-print": {"date-parts": [[1978, 5]]}, "DOI": "10.1016/0016-5085(78)93629-6", "type": "journal-article", "created": {"date-parts": [[2019, 4, 28]], "date-time": "2019-04-28T20:32:15Z", "timestamp": 1556483535000}, "page": "1160", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Comparison of chronic active hepatitis with and without chronic hepatitis B virus infection"], "prefix": "10.1016", "volume": "74", "author": [{"given": "J.", "family": "Rakela", "sequence": "first", "affiliation": []}, {"given": "V.M.", "family": "Edwards", "sequence": "additional", "affiliation": []}, {"given": "J.W.", "family": "Mosley", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Gastroenterology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0016508578936296?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0016508578936296?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 28]], "date-time": "2019-04-28T20:32:15Z", "timestamp": 1556483535000}, "score": 30.957176, "issued": {"date-parts": [[1978, 5]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1978, 5]]}, "issue": "5"}, "alternative-id": ["0016508578936296"], "URL": "http://dx.doi.org/10.1016/0016-5085(78)93629-6", "ISSN": ["0016-5085"], "issn-type": [{"value": "0016-5085", "type": "print"}], "subject": ["Gastroenterology"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T05:21:00Z", "timestamp": 1574313660919}, "reference-count": 44, "publisher": "Springer Science and Business Media LLC", "issue": "3", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2009, 7, 24]], "date-time": "2009-07-24T00:00:00Z", "timestamp": 1248393600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Curr hepatitis rep"], "published-print": {"date-parts": [[2009, 8]]}, "DOI": "10.1007/s11901-009-0014-x", "type": "journal-article", "created": {"date-parts": [[2009, 7, 23]], "date-time": "2009-07-23T13:33:08Z", "timestamp": 1248355988000}, "page": "96-102", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Treatment of chronic hepatitis B virus infection in children"], "prefix": "10.1007", "volume": "8", "author": [{"given": "David E.", "family": "Brumbaugh", "sequence": "first", "affiliation": []}, {"given": "Ronald J.", "family": "Sokol", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2009, 7, 24]]}, "reference": [{"key": "14_CR1", "doi-asserted-by": "crossref", "first-page": "97", "DOI": "10.1046/j.1365-2893.2003.00487.x", "volume": "11", "author": "D. Lavanchy", "year": "2004", "unstructured": "Lavanchy D: Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004, 11:97\u2013107.", "journal-title": "J Viral Hepat"}, {"key": "14_CR2", "first-page": "1", "volume": "57", "author": "A. Wasley", "year": "2008", "unstructured": "Wasley A, Grytdal S, Gallagher K: Surveillance for acute viral hepatitis\u2014United States, 2006. MMWR Surveill Summ 2008, 57:1\u201324.", "journal-title": "MMWR Surveill Summ"}, {"key": "14_CR3", "unstructured": "Centers for Disease Control National Immunization Survey: Estimated Vaccination Coverage with Individual Vaccines and Selected Vaccination Series Among Children 19\u201335 Months of Age by State and Local Area, US National Immunization Survey, Q3/2006-Q2/2007. Available at http://www2a.cdc.gov/nip/coverage/nis/nis_iap.asp?fmt=v&rpt=tab02_antigen_iap&qtr=Q3/2006-Q2/2007 . Accessed July 2008."}, {"key": "14_CR4", "unstructured": "Progress in hepatitis B prevention through universal infant vaccination\u2014China, 1997\u20132006. MMWR Morb Mortal Wkly Rep 2007, 56(18):441\u2013445."}, {"key": "14_CR5", "doi-asserted-by": "crossref", "first-page": "1298", "DOI": "10.1111/j.1478-3231.2008.01844.x", "volume": "28", "author": "J.T. Kao", "year": "2008", "unstructured": "Kao JT, Wang JH, Hung CH, et al.: Changing aetiology of liver dysfunction in the new generation of a hepatitis B and C-endemic area: cross-sectional studies on adolescents born in the first 10 years after universal hepatitis B vaccination. Liver Int 2008, 28:1298\u20131304.", "journal-title": "Liver Int"}, {"key": "14_CR6", "unstructured": "World Health Organization: Summary: global immunization coverage in 2006. Available at http://www.who.int/immunization/newsroom/Global_Immunization_Data.pdf . Accessed July 2008."}, {"key": "14_CR7", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1086/341508", "volume": "186", "author": "G. Marx", "year": "2002", "unstructured": "Marx G, Martin SR, Chicoine JF, Alvarez F: Long-term follow-up of chronic hepatitis B virus infection in children of different ethnic origins. J Infect Dis 2002, 186:295\u2013301.", "journal-title": "J Infect Dis"}, {"key": "14_CR8", "doi-asserted-by": "crossref", "first-page": "759", "DOI": "10.7326/0003-4819-135-9-200111060-00006", "volume": "135", "author": "B.J. McMahon", "year": "2001", "unstructured": "McMahon BJ, Holck P, Bulkow L, Snowball M: Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Ann Intern Med 2001, 135:759\u2013768.", "journal-title": "Ann Intern Med"}, {"key": "14_CR9", "doi-asserted-by": "crossref", "first-page": "32", "DOI": "10.1136/pgmj.2006.044826", "volume": "83", "author": "N. Saikia", "year": "2007", "unstructured": "Saikia N, Talukdar R, Mazumder S, et al.: Management of patients with HBeAg-negative chronic hepatitis B. Postgrad Med J 2007, 83:32\u201339.", "journal-title": "Postgrad Med J"}, {"key": "14_CR10", "doi-asserted-by": "crossref", "first-page": "335", "DOI": "10.1016/j.jhep.2007.11.011", "volume": "48", "author": "G. Fattovich", "year": "2008", "unstructured": "Fattovich G, Bortolotti F, Donato F: Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol 2008, 48:335\u2013352.", "journal-title": "J Hepatol"}, {"key": "14_CR11", "doi-asserted-by": "crossref", "first-page": "385", "DOI": "10.1016/S0022-3476(89)80836-4", "volume": "115", "author": "M.H. Chang", "year": "1989", "unstructured": "Chang MH, Sung JL, Lee CY, et al.: Factors affecting clearance of hepatitis B e antigen in hepatitis B surface antigen carrier children. J Pediatr 1989, 115:385\u2013390.", "journal-title": "J Pediatr"}, {"key": "14_CR12", "doi-asserted-by": "crossref", "first-page": "805", "DOI": "10.1016/0016-5085(90)90972-4", "volume": "99", "author": "F. Bortolotti", "year": "1990", "unstructured": "Bortolotti F, Cadrobbi P, Crivellaro C, et al.: Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood. Gastroenterology 1990, 99:805\u2013810.", "journal-title": "Gastroenterology"}, {"key": "14_CR13", "doi-asserted-by": "crossref", "first-page": "845", "DOI": "10.1086/516538", "volume": "176", "author": "A.A. Evans", "year": "1997", "unstructured": "Evans AA, Fine M, London WT: Spontaneous seroconversion in hepatitis B e antigen-positive chronic hepatitis B: implications for interferon therapy. J Infect Dis 1997, 176:845\u2013850.", "journal-title": "J Infect Dis"}, {"key": "14_CR14", "doi-asserted-by": "crossref", "first-page": "1733", "DOI": "10.1053/j.gastro.2004.09.048", "volume": "127", "author": "Y.H. Ni", "year": "2004", "unstructured": "Ni YH, Chang MH, Wang KJ, et al.: Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma. Gastroenterology 2004, 127:1733\u20131738.", "journal-title": "Gastroenterology"}, {"key": "14_CR15", "doi-asserted-by": "crossref", "first-page": "1522", "DOI": "10.1053/jhep.2002.33638", "volume": "35", "author": "Y.S. Hsu", "year": "2002", "unstructured": "Hsu YS, Chien RN, Yeh CT, et al.: Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 2002, 35:1522\u20131527.", "journal-title": "Hepatology"}, {"key": "14_CR16", "doi-asserted-by": "crossref", "first-page": "168", "DOI": "10.1056/NEJMoa013215", "volume": "347", "author": "H.I. Yang", "year": "2002", "unstructured": "Yang HI, Lu SN, Liaw YF, et al.: Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002, 347:168\u2013174.", "journal-title": "N Engl J Med"}, {"key": "14_CR17", "doi-asserted-by": "crossref", "first-page": "65", "DOI": "10.1001/jama.295.1.65", "volume": "295", "author": "C.J. Chen", "year": "2006", "unstructured": "Chen CJ, Yang HI, Su J, et al.: Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006, 295:65\u201373.", "journal-title": "JAMA"}, {"key": "14_CR18", "doi-asserted-by": "crossref", "first-page": "678", "DOI": "10.1053/j.gastro.2005.11.016", "volume": "130", "author": "U.H. Iloeje", "year": "2006", "unstructured": "Iloeje UH, Yang HI, Su J, et al.: Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006, 130:678\u2013686.", "journal-title": "Gastroenterology"}, {"key": "14_CR19", "doi-asserted-by": "crossref", "first-page": "397", "DOI": "10.1016/j.jpeds.2003.11.022", "volume": "144", "author": "W.H. Wen", "year": "2004", "unstructured": "Wen WH, Chang MH, Hsu HY, et al.: The development of hepatocellular carcinoma among prospectively followed children with chronic hepatitis B virus infection. J Pediatr 2004, 144:397\u2013399.", "journal-title": "J Pediatr"}, {"key": "14_CR20", "doi-asserted-by": "crossref", "first-page": "556", "DOI": "10.1002/hep.21077", "volume": "43", "author": "F. Bortolotti", "year": "2006", "unstructured": "Bortolotti F, Guido M, Bartolacci S, et al.: Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study. Hepatology 2006, 43:556\u2013562.", "journal-title": "Hepatology"}, {"key": "14_CR21", "doi-asserted-by": "crossref", "first-page": "1084", "DOI": "10.1053/gast.2002.36026", "volume": "123", "author": "Y.C. Chen", "year": "2002", "unstructured": "Chen YC, Sheen IS, Chu CM, Liaw YF: Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection. Gastroenterology 2002, 123:1084\u20131089.", "journal-title": "Gastroenterology"}, {"key": "14_CR22", "doi-asserted-by": "crossref", "first-page": "877", "DOI": "10.1016/S0140-6736(87)91371-7", "volume": "2", "author": "C.L. Lai", "year": "1987", "unstructured": "Lai CL, Lok AS, Lin HJ, et al.: Placebo-controlled trial of recombinant alpha 2-interferon in Chinese HBsAg-carrier children. Lancet 1987, 2:877\u2013880.", "journal-title": "Lancet"}, {"key": "14_CR23", "doi-asserted-by": "crossref", "first-page": "26", "DOI": "10.1159/000200221", "volume": "45", "author": "M. Ruiz Moreno", "year": "1990", "unstructured": "Ruiz Moreno M, Jimenez J, Porres JC, et al.: A controlled trial of recombinant interferon-alpha in Caucasian children with chronic hepatitis B. Digestion 1990, 45:26\u201333.", "journal-title": "Digestion"}, {"key": "14_CR24", "doi-asserted-by": "crossref", "first-page": "223", "DOI": "10.1097/00006454-199603000-00010", "volume": "15", "author": "P. Vajro", "year": "1996", "unstructured": "Vajro P, Tedesco M, Fontanella A, et al.: Prolonged and high dose recombinant interferon alpha-2b alone or after prednisone priming accelerates termination of active viral replication in children with chronic hepatitis B infection. Pediatr Infect Dis J 1996, 15:223\u2013231.", "journal-title": "Pediatr Infect Dis J"}, {"key": "14_CR25", "doi-asserted-by": "crossref", "first-page": "988", "DOI": "10.1016/S0016-5085(98)70318-X", "volume": "114", "author": "E.M. Sokal", "year": "1998", "unstructured": "Sokal EM, Conjeevaram HS, Roberts EA, et al.: Interferon alfa therapy for chronic hepatitis B in children: a multinational randomized controlled trial. Gastroenterology 1998, 114:988\u2013995.", "journal-title": "Gastroenterology"}, {"key": "14_CR26", "doi-asserted-by": "crossref", "first-page": "340", "DOI": "10.1016/j.jpeds.2004.05.046", "volume": "145", "author": "G.E. Kobak", "year": "2004", "unstructured": "Kobak GE, MacKenzie T, Sokol RJ, Narkewicz MR: Interferon treatment for chronic hepatitis B: enhanced response in children 5 years old or younger. J Pediatr 2004, 145:340\u2013345.", "journal-title": "J Pediatr"}, {"key": "14_CR27", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1097/00005176-200502000-00011", "volume": "40", "author": "H. Vo Thi Diem", "year": "2005", "unstructured": "Vo Thi Diem H, Bourgois A, Bontems P, et al.: Chronic hepatitis B infection: long term comparison of children receiving interferon alpha and untreated controls. J Pediatr Gastroenterol Nutr 2005, 40:141\u2013145.", "journal-title": "J Pediatr Gastroenterol Nutr"}, {"key": "14_CR28", "doi-asserted-by": "crossref", "first-page": "715", "DOI": "10.1136/gut.46.5.715", "volume": "46", "author": "F. Bortolotti", "year": "2000", "unstructured": "Bortolotti F, Jara P, Barbera C, et al.: Long term effect of alpha interferon in children with chronic hepatitis B. Gut 2000, 46:715\u2013718.", "journal-title": "Gut"}, {"key": "14_CR29", "doi-asserted-by": "crossref", "first-page": "507", "DOI": "10.1002/hep.21513", "volume": "45", "author": "A.S. Lok", "year": "2007", "unstructured": "Lok AS, McMahon BJ: Chronic hepatitis B. Hepatology 2007, 45:507\u2013539.", "journal-title": "Hepatology"}, {"key": "14_CR30", "doi-asserted-by": "crossref", "first-page": "1422", "DOI": "10.1056/NEJM199605303342202", "volume": "334", "author": "C. Niederau", "year": "1996", "unstructured": "Niederau C, Heintges T, Lange S, et al.: Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med 1996, 334:1422\u20131427.", "journal-title": "N Engl J Med"}, {"key": "14_CR31", "doi-asserted-by": "crossref", "first-page": "1660", "DOI": "10.1053/gast.1997.v113.pm9352870", "volume": "113", "author": "D.T. Lau", "year": "1997", "unstructured": "Lau DT, Everhart J, Kleiner DE, et al.: Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa. Gastroenterology 1997, 113:1660\u20131667.", "journal-title": "Gastroenterology"}, {"key": "14_CR32", "doi-asserted-by": "crossref", "first-page": "2682", "DOI": "10.1056/NEJMoa043470", "volume": "352", "author": "G.K. Lau", "year": "2005", "unstructured": "Lau GK, Piratvisuth T, Luo KX, et al.: Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B. N Engl J Med 2005, 352:2682\u20132695.", "journal-title": "N Engl J Med"}, {"key": "14_CR33", "doi-asserted-by": "crossref", "first-page": "1231", "DOI": "10.1097/00005537-200407000-00017", "volume": "114", "author": "A.P. Michaud", "year": "2004", "unstructured": "Michaud AP, Bauman NM, Burke DK, et al.: Spastic diplegia and other motor disturbances in infants receiving interferon-alpha. Laryngoscope 2004, 114:1231\u20131236.", "journal-title": "Laryngoscope"}, {"key": "14_CR34", "doi-asserted-by": "crossref", "first-page": "1706", "DOI": "10.1056/NEJMoa012452", "volume": "346", "author": "M.M. Jonas", "year": "2002", "unstructured": "Jonas MM, Mizerski J, Badia IB, et al.: Clinical trial of lamivudine in children with chronic hepatitis B. N Engl J Med 2002, 346:1706\u20131713.", "journal-title": "N Engl J Med"}, {"key": "14_CR35", "doi-asserted-by": "crossref", "first-page": "225", "DOI": "10.1002/hep.21020", "volume": "43", "author": "E.M. Sokal", "year": "2006", "unstructured": "Sokal EM, Kelly DA, Mizerski J, et al.: Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B. Hepatology 2006, 43:225\u2013232.", "journal-title": "Hepatology"}, {"key": "14_CR36", "doi-asserted-by": "crossref", "first-page": "1863", "DOI": "10.1002/hep.22250", "volume": "47", "author": "M.M. Jonas", "year": "2008", "unstructured": "Jonas MM, Kelly D, Pollack H, et al.: Safety, efficacy, and pharmacokinetics of adefovir diprovoxil in children and adolescents (age 2 to < 18 years) with chronic hepatitis B. Hepatology 2008, 47:1863\u20131871.", "journal-title": "Hepatology"}, {"key": "14_CR37", "doi-asserted-by": "crossref", "first-page": "1011", "DOI": "10.1056/NEJMoa051287", "volume": "354", "author": "C.L. Lai", "year": "2006", "unstructured": "Lai CL, Shouval D, Lok AS, et al.: Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N Engl J Med 2006, 354:1011\u20132100.", "journal-title": "N Engl J Med"}, {"key": "14_CR38", "doi-asserted-by": "crossref", "first-page": "1437", "DOI": "10.1053/j.gastro.2007.08.025", "volume": "133", "author": "R.G. Gish", "year": "2007", "unstructured": "Gish RG, Lok AS, Chang TT, et al.: Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B. Gastroenterology 2007, 133:1437\u20131444.", "journal-title": "Gastroenterology"}, {"key": "14_CR39", "doi-asserted-by": "crossref", "first-page": "318", "DOI": "10.1002/hep.21253", "volume": "44", "author": "F. Bommel van", "year": "2006", "unstructured": "van Bommel F, Zollner B, Sarrazin C, et al.: Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy. Hepatology 2006, 44:318\u2013325.", "journal-title": "Hepatology"}, {"key": "14_CR40", "doi-asserted-by": "crossref", "first-page": "1421", "DOI": "10.1002/hep.20464", "volume": "40", "author": "F. Bommel van", "year": "2004", "unstructured": "van Bommel F, Wunsche T, Mauss S, et al.: Comparison of adefovir and tenofovir in the treatment of lamivudineresistant Hepatitis B virus infection. Hepatology 2004, 40:1421\u20131425.", "journal-title": "Hepatology"}, {"key": "14_CR41", "doi-asserted-by": "crossref", "first-page": "1185", "DOI": "10.1111/j.1478-3231.2007.01580.x", "volume": "27", "author": "D. Rudin", "year": "2007", "unstructured": "Rudin D, Shah SM, Kiss A, et al.: Interferon and lamivudine vs. interferon for hepatitis B e antigen-positive hepatitis B treatment: meta-analysis of randomized controlled trials. Liver Int 2007, 27:1185\u20131193.", "journal-title": "Liver Int"}, {"key": "14_CR42", "first-page": "68", "volume": "39", "author": "I.N. Saltik-Temizel", "year": "2005", "unstructured": "Saltik-Temizel IN, Kocak N, Demir H: Lamivudine and high-dose interferon-alpha combination therapy for naive children with chronic hepatitis B infection. J Clin Gastroenterol 2005, 39:68\u201370.", "journal-title": "J Clin Gastroenterol"}, {"key": "14_CR43", "doi-asserted-by": "crossref", "first-page": "96", "DOI": "10.1111/j.1572-0241.2006.01006.x", "volume": "102", "author": "S.K. Sarin", "year": "2007", "unstructured": "Sarin SK, Sood A, Kumar M, et al.: Effect of lowering HBV DNA levels by initial antiviral therapy before adding immunomodulator on treatment of chronic hepatitis B. Am J Gastroenterol 2007, 102:96\u2013104.", "journal-title": "Am J Gastroenterol"}, {"key": "14_CR44", "doi-asserted-by": "crossref", "first-page": "228", "DOI": "10.1016/j.jpeds.2005.09.020", "volume": "148", "author": "L. D\u2019Antiga", "year": "2006", "unstructured": "D\u2019Antiga L, Aw M, Atkins M, et al.: Combined lamivudine/interferon-alpha treatment in \u201cimmunotolerant\u201d children perinatally infected with hepatitis B: a pilot study. J Pediatr 2006, 148:228\u2013233.", "journal-title": "J Pediatr"}], "container-title": ["Current Hepatitis Reports"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s11901-009-0014-x.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s11901-009-0014-x/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s11901-009-0014-x", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 2]], "date-time": "2019-06-02T00:08:27Z", "timestamp": 1559434107000}, "score": 30.74054, "issued": {"date-parts": [[2009, 7, 24]]}, "references-count": 44, "journal-issue": {"published-print": {"date-parts": [[2009, 8]]}, "issue": "3"}, "alternative-id": ["14"], "URL": "http://dx.doi.org/10.1007/s11901-009-0014-x", "relation": {"cites": []}, "ISSN": ["1540-3416", "1541-0706"], "issn-type": [{"value": "1540-3416", "type": "print"}, {"value": "1541-0706", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T00:42:48Z", "timestamp": 1574469768143}, "reference-count": 0, "publisher": "Southern Medical Association", "issue": "Supplement", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Southern Medical Journal"], "published-print": {"date-parts": [[2003, 11]]}, "DOI": "10.1097/00007611-200311001-00036", "type": "journal-article", "created": {"date-parts": [[2012, 4, 18]], "date-time": "2012-04-18T11:47:21Z", "timestamp": 1334749641000}, "page": "S16-S17", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Treatment of Acute Hepatitis C Virus Infection in a Black Patient with Pegylated Interferon-a plus Ribavirin."], "prefix": "10.14423", "volume": "96", "author": [{"given": "Mark", "family": "Dalton", "sequence": "first", "affiliation": []}, {"given": "Matthew", "family": "Hepburn", "sequence": "additional", "affiliation": []}, {"given": "Eric J.", "family": "Lawitz", "sequence": "additional", "affiliation": []}], "member": "5542", "container-title": ["Southern Medical Journal"], "language": "en", "deposited": {"date-parts": [[2014, 7, 17]], "date-time": "2014-07-17T06:11:37Z", "timestamp": 1405577497000}, "score": 30.455696, "subtitle": [""], "issued": {"date-parts": [[2003, 11]]}, "references-count": 0, "journal-issue": {"issue": "Supplement"}, "URL": "http://dx.doi.org/10.1097/00007611-200311001-00036", "ISSN": ["0038-4348"], "issn-type": [{"value": "0038-4348", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T04:10:23Z", "timestamp": 1574136623849}, "reference-count": 0, "publisher": "Georg Thieme Verlag KG", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Semin Liver Dis"], "published-print": {"date-parts": [[2004, 5]]}, "DOI": "10.1055/s-2004-832928", "type": "journal-article", "created": {"date-parts": [[2004, 9, 2]], "date-time": "2004-09-02T19:25:18Z", "timestamp": 1094153118000}, "page": "47-54", "source": "Crossref", "is-referenced-by-count": 48, "title": ["Treatment of Chronic Hepatitis C Infection with Peginterferons Plus Ribavirin"], "prefix": "10.1055", "volume": "24", "author": [{"given": "Michael W", "family": "Fried", "sequence": "first", "affiliation": []}, {"given": "Stephanos J", "family": "Hadziyannis", "sequence": "additional", "affiliation": []}], "member": "194", "container-title": ["Seminars in Liver Disease"], "language": "de", "link": [{"URL": "http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2004-832928.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 5, 22]], "date-time": "2017-05-22T19:37:01Z", "timestamp": 1495481821000}, "score": 30.274284, "issued": {"date-parts": [[2004, 5]]}, "references-count": 0, "URL": "http://dx.doi.org/10.1055/s-2004-832928", "ISSN": ["0272-8087", "1098-8971"], "issn-type": [{"value": "0272-8087", "type": "print"}, {"value": "1098-8971", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T06:22:54Z", "timestamp": 1574144574200}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2003, 1, 1]], "date-time": "2003-01-01T00:00:00Z", "timestamp": 1041379200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Hepatology"], "published-print": {"date-parts": [[2003]]}, "DOI": "10.1016/s0270-9139(03)81227-2", "type": "journal-article", "created": {"date-parts": [[2004, 11, 5]], "date-time": "2004-11-05T18:00:12Z", "timestamp": 1099677612000}, "page": "730-730", "source": "Crossref", "is-referenced-by-count": 0, "title": ["1189 Mechanisms of ribavirin early antiviral effect in chronic hepatitis C: is it related to ribavirin mutagenic properties inducing? Error catastrophe?"], "prefix": "10.1016", "volume": "38", "author": [{"given": "J", "family": "PAWLOTSKY", "sequence": "first", "affiliation": []}, {"given": "R", "family": "BRILLET", "sequence": "additional", "affiliation": []}, {"given": "C", "family": "HEZODE", "sequence": "additional", "affiliation": []}, {"given": "D", "family": "DHUMEAUX", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Hepatology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0270913903812272?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0270913903812272?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 2]], "date-time": "2019-02-02T09:52:37Z", "timestamp": 1549101157000}, "score": 29.887072, "issued": {"date-parts": [[2003]]}, "references-count": 0, "alternative-id": ["S0270913903812272"], "URL": "http://dx.doi.org/10.1016/s0270-9139(03)81227-2", "ISSN": ["0270-9139"], "issn-type": [{"value": "0270-9139", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T22:58:36Z", "timestamp": 1575154716478}, "reference-count": 13, "publisher": "Springer Science and Business Media LLC", "issue": "5", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1994, 9, 1]], "date-time": "1994-09-01T00:00:00Z", "timestamp": 778377600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Infection"], "published-print": {"date-parts": [[1994, 9]]}, "DOI": "10.1007/bf01715540", "type": "journal-article", "created": {"date-parts": [[2005, 6, 12]], "date-time": "2005-06-12T11:15:51Z", "timestamp": 1118574951000}, "page": "330-332", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Treatment of chronic replicative hepatitis B virus infection with short-term continuous infusion of foscarnet"], "prefix": "10.1007", "volume": "22", "author": [{"given": "R.", "family": "Schvarcz", "sequence": "first", "affiliation": []}, {"given": "Ola", "family": "Weiland", "sequence": "additional", "affiliation": []}, {"given": "B. G.", "family": "Hansson", "sequence": "additional", "affiliation": []}, {"given": "J. -O.", "family": "Lernestedt", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"issue": "Suppl.", "key": "BF01715540_CR1", "doi-asserted-by": "crossref", "first-page": "100", "DOI": "10.1016/0168-8278(90)90173-O", "volume": "11", "author": "J. Hoofnagle", "year": "1990", "unstructured": "Hoofnagle, J. Alpha-interferon therapy of chronic hepatitis B. Current status and recommendations. J. Hepatol. (Suppl.) 11 (1990) 100\u2013107.", "journal-title": "J. Hepatol."}, {"key": "BF01715540_CR2", "doi-asserted-by": "crossref", "first-page": "387", "DOI": "10.1016/0163-7258(82)90074-2", "volume": "19", "author": "B. \u00d6berg", "year": "1983", "unstructured": "\u00d6berg, B. Antiviral effects of phosphonoformate. Pharmacol. Ther. 19 (1983) 387\u2013415.", "journal-title": "Pharmacol. Ther."}, {"key": "BF01715540_CR3", "doi-asserted-by": "crossref", "first-page": "301", "DOI": "10.1016/0166-3542(89)90057-0", "volume": "12", "author": "B. L\u00f6fgren", "year": "1989", "unstructured": "L\u00f6fgren, B., Nordenfeldt, E., \u00d6berg, B. Inhibition of RNA- and DNA-dependent duck hepatitis B virus DNA polymerase activity by nucleoside and pyrophosphate analogs. Antiviral Res. 12 (1989) 301\u2013310.", "journal-title": "Antiviral Res."}, {"key": "BF01715540_CR4", "first-page": "449", "volume": "90", "author": "E. Nordenfeldt", "year": "1982", "unstructured": "Nordenfeldt, E., Widell, A., Hansson, B., L\u00f6fgren, B., M\u00f6ller-Nielsen, C., \u00d6berg, B. Noin vivo effect of trisodium phosphonoformate on woodchuck hepatitis virus production. Acta Path. Microbiol. Immunol. Scand. Sec. B 90 (1982) 449\u2013451.", "journal-title": "Acta Path. Microbiol. Immunol. Scand. Sec. B"}, {"key": "BF01715540_CR5", "doi-asserted-by": "crossref", "first-page": "818", "DOI": "10.1016/0016-5085(86)90681-5", "volume": "91", "author": "A. Sherker", "year": "1986", "unstructured": "Sherker, A., Hirota, K., Omata, M., Okuda, K. Foscarnet decreases serum and liver duck hepatitis B virus DNA in chronically infected ducks. Gastroenterology 91 (1986) 818\u2013824.", "journal-title": "Gastroenterology"}, {"key": "BF01715540_CR6", "author": "G. Hedin", "first-page": "947", "year": "1988", "unstructured": "Hedin, G., Weiland, O., Ljunggren, K., Nordenfeldt, E., Hansson, B., Lernestedt, J., \u00d6berg, B. Treatment with foscarnet of fulminant hepatitis B and fulminant hepatitis B and D coinfection. In:Zuckermann, A. J. (ed): Viral hepatitis and liver disease. Alan R. Liss, Inc., New York 1988, pp. 947\u2013952.", "volume-title": "Viral hepatitis and liver disease"}, {"key": "BF01715540_CR7", "doi-asserted-by": "crossref", "first-page": "152", "DOI": "10.1002/jmv.1890290214", "volume": "29", "author": "V. Bain", "year": "1989", "unstructured": "Bain, V., Daniels, H., Chanas, A., Alexander, G., Williams, R. Foscarnet therapy in chronic hepatitis B virus e antigen carriers. J. Med. Virol. 29 (1989) 152\u2013155.", "journal-title": "J. Med. Virol."}, {"key": "BF01715540_CR8", "doi-asserted-by": "crossref", "first-page": "255", "DOI": "10.1016/S0168-8278(05)80254-5", "volume": "18", "author": "S. Antinori", "year": "1993", "unstructured": "Antinori, S., Esposito, R., d'Aminio Monforte, A., Moroni, M. Foscarnet treatment of chronic hepatitis B in an HIV-positive patient. J. Hepatol. 18 (1993) 255\u2013256.", "journal-title": "J. Hepatol."}, {"key": "BF01715540_CR9", "doi-asserted-by": "crossref", "first-page": "538", "DOI": "10.1002/hep.1840170403", "volume": "17", "author": "Y. Zhang", "year": "1993", "unstructured": "Zhang, Y., Hansson, B., Kuo, L., Widell, A., Nordenfeldt, E. Hepatitis B virus DNA in serum and liver is commonly found in Chinese patients with chronic liver disease despite the presence of antibodies to HBsAg. Hepatology 17 (1993) 538\u2013544.", "journal-title": "Hepatology"}, {"key": "BF01715540_CR10", "first-page": "169", "volume": "88", "author": "E. Nordenfeldt", "year": "1980", "unstructured": "Nordenfeldt, E., \u00d6berg, B., Helgestrand, E., Miller, E. Inhibition of hepatitis B Dane particle DNA polymerase activity by pyrophosphate analogs. Acta Path. Microbiol. Immunol. Scand. Sect. B 88 (1980) 169\u2013175.", "journal-title": "Acta Path. Microbiol. Immunol. Scand. Sect. B"}, {"key": "BF01715540_CR11", "doi-asserted-by": "crossref", "first-page": "447", "DOI": "10.1016/S0378-4347(00)82968-0", "volume": "488", "author": "K. Pettersson", "year": "1989", "unstructured": "Pettersson, K., Nordgren, T., Westerlund, D. Determination of phosphonoformate (foscarnet) on biological fluids by ion-pair reversed-phase liquid chromatography. J. Chromatog. 488 (1989) 447\u2013455.", "journal-title": "J. Chromatog."}, {"key": "BF01715540_CR12", "unstructured": "Nordenfeldt, E., L\u00f6fgren, B., Zhang, Y.: Treatment of duck hepatitis B virus infected ducks with combination of ganciclovir and foscarnet. Abstract, ISVHLD Tokyo (1993) p. 155."}, {"key": "BF01715540_CR13", "author": "B. Hansson", "first-page": "421", "year": "1990", "unstructured": "Hansson, B., Riesbeck, K., Nordenfeldt, E., Weiland, O. Successful treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection explained by inhibitory effect on the immune response. In:Gerin, J., Rizetto, M., Purcell, B. (eds): The hepatitis delta virus. Alan R. Liss, Inc. New York 1990, pp. 421\u2013427.", "volume-title": "The hepatitis delta virus"}], "container-title": ["Infection"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/BF01715540.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/BF01715540/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/BF01715540", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 8]], "date-time": "2019-05-08T13:03:51Z", "timestamp": 1557320631000}, "score": 29.790302, "issued": {"date-parts": [[1994, 9]]}, "references-count": 13, "journal-issue": {"published-print": {"date-parts": [[1994, 9]]}, "issue": "5"}, "alternative-id": ["BF01715540"], "URL": "http://dx.doi.org/10.1007/bf01715540", "relation": {"cites": []}, "ISSN": ["0300-8126", "1439-0973"], "issn-type": [{"value": "0300-8126", "type": "print"}, {"value": "1439-0973", "type": "electronic"}], "subject": ["Microbiology (medical)", "Infectious Diseases", "General Medicine"]}, {"institution": {"name": "ISRCTN", "place": ["London, UK"], "acronym": ["-"]}, "indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T14:51:08Z", "timestamp": 1574520668680}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "content-domain": {"domain": ["www.isrctn.com"], "crossmark-restriction": true}, "DOI": "10.1186/isrctn74271466", "type": "dataset", "created": {"date-parts": [[2012, 12, 6]], "date-time": "2012-12-06T01:06:25Z", "timestamp": 1354755985000}, "update-policy": "http://dx.doi.org/10.1186/isrctn_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Study on chronic hepatitis C treatment with interferon alpha, ribavirin and amantadine in naive patients."], "prefix": "10.1186", "author": [{"given": "K J", "family": "van Erpecum", "sequence": "first", "affiliation": []}], "member": "297", "content-created": {"date-parts": [[2012, 12, 6]]}, "container-title": ["http://isrctn.org/>"], "deposited": {"date-parts": [[2015, 6, 12]], "date-time": "2015-06-12T14:13:06Z", "timestamp": 1434118386000}, "score": 29.694221, "issued": {"date-parts": [[2012, 12, 6]]}, "references-count": 0, "URL": "http://dx.doi.org/10.1186/isrctn74271466"}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T04:16:12Z", "timestamp": 1574396172472}, "reference-count": 48, "publisher": "Wiley", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 2069, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Hepatology"], "published-print": {"date-parts": [[2010]]}, "DOI": "10.1002/hep.23461", "type": "journal-article", "created": {"date-parts": [[2009, 11, 30]], "date-time": "2009-11-30T20:02:48Z", "timestamp": 1259611368000}, "page": "NA-NA", "source": "Crossref", "is-referenced-by-count": 9, "title": ["Hepatitis B virus infection among American patients with chronic hepatitis C virus infection: Prevalence, racial/ethnic differences, and viral interactions"], "prefix": "10.1002", "author": [{"given": "Edmund J.", "family": "Bini", "sequence": "first", "affiliation": []}, {"given": "Ponni V.", "family": "Perumalswami", "sequence": "additional", "affiliation": []}], "member": "311", "reference": [{"key": "10.1002/hep.23461-BIB1", "first-page": "1147", "article-title": "Prevalence and significance of hepatitis C viremia in chronic active hepatitis B", "volume": "89", "author": "Crespo", "year": "1994", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.23461-BIB2", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1016/S0168-8278(98)80198-0", "article-title": "Characteristics of patients with dual infection by hepatitis B and C viruses", "volume": "28", "author": "Zarski", "year": "1998", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.23461-BIB3", "doi-asserted-by": "crossref", "first-page": "64", "DOI": "10.1002/hep.1840140111", "article-title": "The significance of antibody to hepatitis C virus in patients with chronic hepatitis B", "volume": "14", "author": "Fong", "year": "1991", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.23461-BIB4", "first-page": "1404", "article-title": "Dual infection with hepatitis C and B viruses: clinical and histological study in Saudi patients", "volume": "44", "author": "Mohamed", "year": "1997", "journal-title": "Hepatogastroenterology"}, {"key": "10.1002/hep.23461-BIB5", "doi-asserted-by": "crossref", "first-page": "144", "DOI": "10.1007/s15010-004-3080-6", "article-title": "Influence of chronic coinfection with hepatitis B and C virus on liver histology", "volume": "32", "author": "Sagnelli", "year": "2004", "journal-title": "Infection"}, {"key": "10.1002/hep.23461-BIB6", "doi-asserted-by": "crossref", "first-page": "515", "DOI": "10.1111/j.1440-1746.2006.04547.x", "article-title": "Comparison of liver histopathology between chronic hepatitis C patients and chronic hepatitis B and C-coinfected patients", "volume": "22", "author": "Lee", "year": "2007", "journal-title": "J Gastroenterol Hepatol"}, {"key": "10.1002/hep.23461-BIB7", "doi-asserted-by": "crossref", "first-page": "1090", "DOI": "10.1002/hep.22794", "article-title": "HBV superinfection in HCV chronic carriers: a disease that is frequently severe but associated with the eradication of HCV", "volume": "49", "author": "Sagnelli", "year": "2009", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.23461-BIB8", "doi-asserted-by": "crossref", "first-page": "347", "DOI": "10.1002/(SICI)1097-0215(19980130)75:3<347::AID-IJC4>3.0.CO;2-2", "article-title": "A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma", "volume": "75", "author": "Donato", "year": "1998", "journal-title": "Int J Cancer"}, {"key": "10.1002/hep.23461-BIB9", "doi-asserted-by": "crossref", "first-page": "607", "DOI": "10.1038/sj.bjc.6602333", "article-title": "A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China", "volume": "92", "author": "Shi", "year": "2005", "journal-title": "Br J Cancer"}, {"key": "10.1002/hep.23461-BIB10", "doi-asserted-by": "crossref", "first-page": "S158", "DOI": "10.1097/00004836-200411003-00008", "article-title": "Global epidemiology of hepatitis B virus", "volume": "38", "author": "Custer", "year": "2004", "journal-title": "J Clin Gastroenterol"}, {"key": "10.1002/hep.23461-BIB11", "doi-asserted-by": "crossref", "first-page": "S47", "DOI": "10.1016/0264-410X(95)80050-N", "article-title": "Global programme for control of hepatitis B infection", "volume": "13", "author": "Kane", "year": "1995", "journal-title": "Vaccine"}, {"key": "10.1002/hep.23461-BIB12", "first-page": "341", "article-title": "Hepatitis C: global prevalence", "volume": "72", "author": "World Health Organization", "year": "1997", "journal-title": "Wkly Epidemiol Rec"}, {"key": "10.1002/hep.23461-BIB13", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.1046/j.1365-2893.1999.6120139.x", "article-title": "Global surveillance and control of hepatitis C", "volume": "6", "author": "World Health Organization", "year": "1999", "journal-title": "J Viral Hepat"}, {"key": "10.1002/hep.23461-BIB14", "doi-asserted-by": "crossref", "first-page": "257", "DOI": "10.1002/hep.510300109", "article-title": "The long-term course of chronic hepatitis B", "volume": "30", "author": "Di Marco", "year": "1999", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.23461-BIB15", "doi-asserted-by": "crossref", "first-page": "1036", "DOI": "10.1016/S0168-8278(03)00470-7", "article-title": "Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study", "volume": "39", "author": "Gaeta", "year": "2003", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.23461-BIB16", "doi-asserted-by": "crossref", "first-page": "400", "DOI": "10.1093/infdis/163.2.400", "article-title": "Hepatitis C virus infection in chronic hepatitis B virus carriers", "volume": "163", "author": "Fattovich", "year": "1991", "journal-title": "J Infect Dis"}, {"key": "10.1002/hep.23461-BIB17", "doi-asserted-by": "crossref", "first-page": "509", "DOI": "10.1016/S0168-8278(94)80094-4", "article-title": "Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients", "volume": "21", "author": "Ohkawa", "year": "1994", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.23461-BIB18", "doi-asserted-by": "crossref", "first-page": "159", "DOI": "10.1016/S0168-8278(05)80389-7", "article-title": "Coinfection of hepatitis C virus in patients with chronic hepatitis B infection", "volume": "21", "author": "Sato", "year": "1994", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.23461-BIB19", "doi-asserted-by": "crossref", "first-page": "636", "DOI": "10.1046/j.1440-1746.2001.02494.x", "article-title": "Influence of hepatitis C virus on the profiles of patients with chronic hepatitis B virus infection", "volume": "16", "author": "Dai", "year": "2001", "journal-title": "J Gastroenterol Hepatol"}, {"key": "10.1002/hep.23461-BIB20", "first-page": "20", "article-title": "Hepatitis B/C virus co-infection in Iran: a seroepidemiological study", "volume": "18", "author": "Semnani", "year": "2007", "journal-title": "Turk J Gastroenterol"}, {"key": "10.1002/hep.23461-BIB21", "doi-asserted-by": "crossref", "first-page": "14", "DOI": "10.2105/AJPH.89.1.14", "article-title": "Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994", "volume": "89", "author": "McQuillan", "year": "1999", "journal-title": "Am J Public Health"}, {"key": "10.1002/hep.23461-BIB22", "doi-asserted-by": "crossref", "first-page": "1952", "DOI": "10.2105/AJPH.94.11.1952", "article-title": "Racial and ethnic differences in the seroprevalence of 6 infectious diseases in the United States: data from NHANES III, 1988-1994", "volume": "94", "author": "McQuillan", "year": "2004", "journal-title": "Am J Public Health"}, {"key": "10.1002/hep.23461-BIB23", "doi-asserted-by": "crossref", "first-page": "556", "DOI": "10.1056/NEJM199908193410802", "article-title": "The prevalence of hepatitis C virus infection in the United States, 1988 through 1994", "volume": "341", "author": "Alter", "year": "1999", "journal-title": "N Engl J Med"}, {"key": "10.1002/hep.23461-BIB24", "doi-asserted-by": "crossref", "first-page": "705", "DOI": "10.7326/0003-4819-144-10-200605160-00004", "article-title": "The prevalence of hepatitis C virus infection in the United States, 1999 through 2002", "volume": "144", "author": "Armstrong", "year": "2006", "journal-title": "Ann Intern Med"}, {"key": "10.1002/hep.23461-BIB25", "doi-asserted-by": "crossref", "first-page": "1518", "DOI": "10.1111/j.1572-0241.2002.05707.x", "article-title": "Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection", "volume": "97", "author": "Squadrito", "year": "2002", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.23461-BIB26", "doi-asserted-by": "crossref", "first-page": "1529", "DOI": "10.1016/0016-5085(93)90161-5", "article-title": "Clinical and virological profiles in patients with multiple hepatitis virus infections", "volume": "105", "author": "Pontisso", "year": "1993", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.23461-BIB27", "first-page": "38", "article-title": "The interaction between hepatitis B virus and hepatitis C virus in acute and chronic liver disease", "volume": "22", "author": "Alberti", "year": "1995", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.23461-BIB28", "doi-asserted-by": "crossref", "first-page": "831", "DOI": "10.1093/infdis/165.5.831", "article-title": "Role of hepatitis C virus infection in spontaneous hepatitis B surface antigen clearance during chronic hepatitis B virus infection", "volume": "165", "author": "Sheen", "year": "1992", "journal-title": "J Infect Dis"}, {"key": "10.1002/hep.23461-BIB29", "doi-asserted-by": "crossref", "first-page": "445", "DOI": "10.1007/BF02471908", "article-title": "Viral replication in patients with concomitant hepatitis B and C virus infections", "volume": "16", "author": "Crespo", "year": "1997", "journal-title": "Eur J Clin Microbiol Infect Dis"}, {"key": "10.1002/hep.23461-BIB30", "doi-asserted-by": "crossref", "first-page": "46", "DOI": "10.1002/hep.22951", "article-title": "Hepatitis B and C virus coinfection: a novel model system reveals the absence of direct viral interference", "volume": "50", "author": "Bellecave", "year": "2009", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.23461-BIB31", "doi-asserted-by": "crossref", "first-page": "446", "DOI": "10.1016/j.jhep.2009.04.025", "article-title": "Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells", "volume": "51", "author": "Eyre", "year": "2009", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.23461-BIB32", "doi-asserted-by": "crossref", "first-page": "696", "DOI": "10.1016/0168-8278(95)80226-6", "article-title": "Histological grading and staging of chronic hepatitis", "volume": "22", "author": "Ishak", "year": "1995", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.23461-BIB33", "doi-asserted-by": "crossref", "first-page": "372", "DOI": "10.1016/0168-8278(91)90084-O", "article-title": "Classification of chronic viral hepatitis: a need for reassessment", "volume": "13", "author": "Scheuer", "year": "1991", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.23461-BIB34", "doi-asserted-by": "crossref", "first-page": "2467", "DOI": "10.1111/j.1572-0241.1999.01377.x", "article-title": "Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions", "volume": "94", "author": "Brunt", "year": "1999", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.23461-BIB35", "doi-asserted-by": "crossref", "first-page": "1409", "DOI": "10.1053/j.gastro.2004.02.073", "article-title": "Chronic hepatitis C with normal aminotransferase levels", "volume": "126", "author": "Ahmed", "year": "2004", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.23461-BIB36", "first-page": "S179", "article-title": "Treatment of patients with hepatitis C and normal serum aminotransferase levels", "volume": "36", "author": "Bacon", "year": "2002", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.23461-BIB37", "doi-asserted-by": "crossref", "first-page": "868", "DOI": "10.1002/hep.510270333", "article-title": "Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity", "volume": "27", "author": "Mathurin", "year": "1998", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.23461-BIB38", "doi-asserted-by": "crossref", "first-page": "825", "DOI": "10.1016/S0140-6736(96)07642-8", "article-title": "Natural history of liver fibrosis progression in patients with chronic hepatitis C", "volume": "349", "author": "Poynard", "year": "1997", "journal-title": "Lancet"}, {"key": "10.1002/hep.23461-BIB39", "doi-asserted-by": "crossref", "first-page": "858", "DOI": "10.1111/j.1572-0241.2001.03633.x", "article-title": "Prevalence of hepatitis A virus and hepatitis B virus immunity in patients with polymerase chain reaction-confirmed hepatitis C: implications for vaccination strategy", "volume": "96", "author": "Siddiqui", "year": "2001", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.23461-BIB40", "first-page": "89", "article-title": "Prevalence of antibodies against hepatitis C virus and hepatitis B coinfection in healthy population in Bulgaria. A seroepidemiological study", "volume": "50", "author": "Atanasova", "year": "2004", "journal-title": "Minerva Gastroenterol Dietol"}, {"key": "10.1002/hep.23461-BIB41", "doi-asserted-by": "crossref", "first-page": "459", "DOI": "10.1016/S1542-3565(04)00160-0", "article-title": "Hepatitis C in a Los Angeles public hepatitis clinic: demographic and biochemical differences associated with race-ethnicity", "volume": "2", "author": "Celona", "year": "2004", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1002/hep.23461-BIB42", "doi-asserted-by": "crossref", "first-page": "38", "DOI": "10.1016/j.jhep.2005.01.031", "article-title": "Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis", "volume": "43", "author": "Gordon", "year": "2005", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.23461-BIB43", "doi-asserted-by": "crossref", "first-page": "679", "DOI": "10.1111/j.1440-1746.2008.05361.x", "article-title": "Hepatitis B and fatty liver: causal or coincidental?", "volume": "23", "author": "Fan", "year": "2008", "journal-title": "J Gastroenterol Hepatol"}, {"key": "10.1002/hep.23461-BIB44", "doi-asserted-by": "crossref", "first-page": "1082", "DOI": "10.1111/j.1440-1746.2008.05478.x", "article-title": "Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors", "volume": "23", "author": "Peng", "year": "2008", "journal-title": "J Gastroenterol Hepatol"}, {"key": "10.1002/hep.23461-BIB45", "doi-asserted-by": "crossref", "first-page": "512", "DOI": "10.1097/MEG.0b013e328326792e", "article-title": "Liver steatosis in patients with chronic hepatitis B infection: host and viral risk factors", "volume": "21", "author": "Minakari", "year": "2009", "journal-title": "Eur J Gastroenterol Hepatol"}, {"key": "10.1002/hep.23461-BIB46", "doi-asserted-by": "crossref", "first-page": "1411", "DOI": "10.1093/infdis/169.6.1411", "article-title": "Lower serum hepatitis C virus RNA titers in patients with concurrent chronic hepatitis B virus infection", "volume": "169", "author": "Francois", "year": "1994", "journal-title": "J Infect Dis"}, {"key": "10.1002/hep.23461-BIB47", "doi-asserted-by": "crossref", "first-page": "236", "DOI": "10.1002/jmv.1890450222", "article-title": "Dominant replication of either virus in dual infection with hepatitis viruses B and C", "volume": "45", "author": "Koike", "year": "1995", "journal-title": "J Med Virol"}, {"key": "10.1002/hep.23461-BIB48", "doi-asserted-by": "crossref", "first-page": "100", "DOI": "10.1002/hep.20944", "article-title": "Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients", "volume": "43", "author": "Raimondo", "year": "2006", "journal-title": "HEPATOLOGY"}], "container-title": ["Hepatology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.23461", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 24]], "date-time": "2019-02-24T22:02:23Z", "timestamp": 1551045743000}, "score": 29.694107, "issued": {"date-parts": [[2010]]}, "references-count": 48, "URL": "http://dx.doi.org/10.1002/hep.23461", "relation": {"cites": []}, "ISSN": ["0270-9139", "1527-3350"], "issn-type": [{"value": "0270-9139", "type": "print"}, {"value": "1527-3350", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T19:32:46Z", "timestamp": 1574451166302}, "reference-count": 23, "publisher": "Wiley", "issue": "4", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 1818, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Hepatology"], "DOI": "10.1002/hep.23842", "type": "journal-article", "created": {"date-parts": [[2010, 7, 29]], "date-time": "2010-07-29T15:13:13Z", "timestamp": 1280416393000}, "page": "1225-1231", "source": "Crossref", "is-referenced-by-count": 33, "title": ["Risk factors for infection during treatment with peginterferon alfa and ribavirin for chronic hepatitis C"], "prefix": "10.1002", "volume": "52", "author": [{"given": "Robert", "family": "Roomer", "sequence": "first", "affiliation": []}, {"given": "Bettina E.", "family": "Hansen", "sequence": "additional", "affiliation": []}, {"given": "Harry L. A.", "family": "Janssen", "sequence": "additional", "affiliation": []}, {"given": "Robert J.", "family": "de Knegt", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2010, 9, 9]]}, "reference": [{"key": "10.1002/hep.23842-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "825", "DOI": "10.1016/S0140-6736(96)07642-8", "article-title": "Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups", "volume": "349", "author": "Poynard", "year": "1997", "journal-title": "Lancet"}, {"key": "10.1002/hep.23842-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "975", "DOI": "10.1056/NEJMoa020047", "article-title": "Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection", "volume": "347", "author": "Fried", "year": "2002", "journal-title": "N Engl J Med"}, {"key": "10.1002/hep.23842-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "346", "DOI": "10.7326/0003-4819-140-5-200403020-00010", "article-title": "Peginterferon-alph2 and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose", "volume": "140", "author": "Hadziyannis", "year": "2004", "journal-title": "Ann Intern Med"}, {"key": "10.1002/hep.23842-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "958", "DOI": "10.1016/S0140-6736(01)06102-5", "article-title": "Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial", "volume": "358", "author": "Manns", "year": "2001", "journal-title": "Lancet"}, {"issue": "Suppl. 1", "key": "10.1002/hep.23842-BIB5|cit5", "first-page": "S237", "article-title": "Side effects of therapy of hepatitis C and their management", "volume": "36", "author": "Fried", "year": "2002", "journal-title": "Hepatology"}, {"key": "10.1002/hep.23842-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "250", "DOI": "10.1007/s15010-007-7132-6", "article-title": "Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin", "volume": "36", "author": "Antonini", "year": "2008", "journal-title": "Infection"}, {"key": "10.1002/hep.23842-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "1674", "DOI": "10.1086/504386", "article-title": "Rate of infectious complications during interferon-based therapy for hepatitis C is not related to neutropenia", "volume": "42", "author": "Cooper", "year": "2006", "journal-title": "Clin Infect Dis"}, {"key": "10.1002/hep.23842-BIB8|cit8", "first-page": "627", "article-title": "Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation?", "volume": "9", "author": "Puoti", "year": "2004", "journal-title": "Antivir Ther"}, {"key": "10.1002/hep.23842-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "1273", "DOI": "10.1053/jhep.2002.36502", "article-title": "Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C", "volume": "36", "author": "Soza", "year": "2002", "journal-title": "Hepatology"}, {"key": "10.1002/hep.23842-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "1000", "DOI": "10.1111/j.1365-2036.2009.03957.x", "article-title": "Bacterial infection and neutropenia during peginterferon plus ribavirin combination therapy in patients with chronic hepatitis C with and without baseline neutropenia in clinical practice", "volume": "29", "author": "Yang", "year": "2009", "journal-title": "Aliment Pharmacol Ther"}, {"issue": "Suppl. 1", "key": "10.1002/hep.23842-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "S9", "DOI": "10.1097/01.mcg.0000142583.00102.45", "article-title": "The use of growth factors to manage the hematologic side effects of PEG-interferon alfa and ribavirin", "volume": "39", "author": "Collantes", "year": "2005", "journal-title": "J Clin Gastroenterol"}, {"key": "10.1002/hep.23842-BIB12|cit12", "first-page": "1217", "article-title": "Gamma-glutamyltransferase and rapid virological response as predictors of successful treatment with experimental or standard peginterferon-alpha-2b in chronic hepatitis C non-responders", "volume": "27", "author": "Bergmann", "year": "2007", "journal-title": "Liver Int"}, {"key": "10.1002/hep.23842-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "1061", "DOI": "10.1053/gast.2002.35950", "article-title": "Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C", "volume": "123", "author": "McHutchison", "year": "2002", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.23842-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "103", "DOI": "10.1053/j.gastro.2006.11.011", "article-title": "Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C", "volume": "132", "author": "Shiffman", "year": "2007", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.23842-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "328", "DOI": "10.7326/0003-4819-64-2-328", "article-title": "Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia", "volume": "64", "author": "Bodey", "year": "1966", "journal-title": "Ann Intern Med"}, {"issue": "Suppl. D", "key": "10.1002/hep.23842-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "65", "DOI": "10.1093/jac/41.suppl_4.65", "article-title": "The evolution of the empirical management of fever and neutropenia in cancer patients", "volume": "41", "author": "Viscoli", "year": "1998", "journal-title": "J Antimicrob Chemother"}, {"issue": "Suppl. 4", "key": "10.1002/hep.23842-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "S82", "DOI": "10.1016/S0959-8049(01)00461-0", "article-title": "Management of infection in cancer patients. studies of the EORTC International Antimicrobial Therapy Group (IATG)", "volume": "38", "author": "Viscoli", "year": "2002", "journal-title": "Eur J Cancer"}, {"issue": "Suppl. 4", "key": "10.1002/hep.23842-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "S240", "DOI": "10.1086/427329", "article-title": "Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification", "volume": "40", "author": "Viscoli", "year": "2005", "journal-title": "Clin Infect Dis"}, {"key": "10.1002/hep.23842-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "847", "DOI": "10.1111/j.1749-6632.2009.04623.x", "article-title": "Treatment with PEG-interferon and ribavirin for chronic hepatitis C increases neutrophil and monocyte chemotaxis", "volume": "1173", "author": "Giorgini", "year": "2009", "journal-title": "Ann N Y Acad Sci"}, {"key": "10.1002/hep.23842-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "719", "DOI": "10.1016/j.jhep.2008.11.015", "article-title": "Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: a retrospective study", "volume": "50", "author": "Carrion", "year": "2009", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.23842-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "1041", "DOI": "10.1111/j.1432-2277.2009.00927.x", "article-title": "The aging of the immune system", "volume": "22", "author": "Weiskopf", "year": "2009", "journal-title": "Transpl Int"}, {"key": "10.1002/hep.23842-BIB22|cit22", "doi-asserted-by": "crossref", "first-page": "29", "DOI": "10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V", "article-title": "Impaired leucocyte functions in diabetic patients", "volume": "14", "author": "Delamaire", "year": "1997", "journal-title": "Diabet Med"}, {"key": "10.1002/hep.23842-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "239", "DOI": "10.1016/S0165-2478(00)00255-8", "article-title": "Innate immune response mechanisms in non-insulin dependent diabetes mellitus patients assessed by flow cytoenzymology", "volume": "74", "author": "Llorente", "year": "2000", "journal-title": "Immunol Lett"}], "container-title": ["Hepatology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.23842", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 2]], "date-time": "2019-03-02T22:48:32Z", "timestamp": 1551566912000}, "score": 29.523241, "issued": {"date-parts": [[2010, 9, 9]]}, "references-count": 23, "journal-issue": {"issue": "4"}, "URL": "http://dx.doi.org/10.1002/hep.23842", "relation": {"cites": []}, "ISSN": ["0270-9139"], "issn-type": [{"value": "0270-9139", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T20:23:32Z", "timestamp": 1574108612386}, "reference-count": 0, "publisher": "BMJ", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Gut"], "published-print": {"date-parts": [[2004, 1, 1]]}, "DOI": "10.1136/gut.53.1.130", "type": "journal-article", "created": {"date-parts": [[2003, 12, 18]], "date-time": "2003-12-18T23:23:28Z", "timestamp": 1071789808000}, "page": "130-135", "source": "Crossref", "is-referenced-by-count": 28, "title": ["Randomised, double blind, placebo controlled trial of interferon, ribavirin, and amantadine versus interferon, ribavirin, and placebo in treatment naive patients with chronic hepatitis C"], "prefix": "10.1136", "volume": "53", "author": [{"given": "P J", "family": "Thuluvath", "sequence": "first", "affiliation": []}], "member": "239", "container-title": ["Gut"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1136/gut.53.1.130", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T20:28:58Z", "timestamp": 1482524938000}, "score": 29.372835, "issued": {"date-parts": [[2004, 1, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2004, 1, 1]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1136/gut.53.1.130", "ISSN": ["0017-5749"], "issn-type": [{"value": "0017-5749", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T14:10:41Z", "timestamp": 1575209441581}, "reference-count": 0, "publisher": "American College of Physicians", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Ann Intern Med"], "published-print": {"date-parts": [[2004, 3, 2]]}, "DOI": "10.7326/0003-4819-140-5-200403020-00010", "type": "journal-article", "created": {"date-parts": [[2013, 4, 12]], "date-time": "2013-04-12T18:19:43Z", "timestamp": 1365790783000}, "page": "346", "source": "Crossref", "is-referenced-by-count": 2034, "title": ["Peginterferon-\u03b12a and Ribavirin Combination Therapy in Chronic Hepatitis C"], "prefix": "10.7326", "volume": "140", "author": [{"given": "Stephanos J.", "family": "Hadziyannis", "sequence": "first", "affiliation": []}], "member": "4285", "container-title": ["Annals of Internal Medicine"], "language": "en", "deposited": {"date-parts": [[2013, 10, 7]], "date-time": "2013-10-07T16:31:28Z", "timestamp": 1381163488000}, "score": 29.372835, "subtitle": ["A Randomized Study of Treatment Duration and Ribavirin Dose"], "issued": {"date-parts": [[2004, 3, 2]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2004, 3, 2]]}, "issue": "5"}, "URL": "http://dx.doi.org/10.7326/0003-4819-140-5-200403020-00010", "ISSN": ["0003-4819"], "issn-type": [{"value": "0003-4819", "type": "print"}], "subject": ["Internal Medicine", "General Medicine"]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}